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CHAPTER 1

INTRODUCTION

1.1. Summary
This study aimed at identifying the functions of Cyclin Y using Drosophila
melanogaster as a model organism. Cyclins are a family of conserved proteins. In
human, there are 15 known Cyclins from Cyclin A to Cyclin Y (Gopinathan et al.,
2011). Cyclins function in regulation of Cyclin dependent kinase (Cdk) activity
(Gopinathan et al., 2011; Lim and Kaldis, 2013). The Cyclin box allows cyclins to bind
to Cdks. There are more than 20 known Cdks (Gopinathan et al., 2011; Lim and
Kaldis, 2013). While cyclins are known for their essential roles in regulating the cell
cycle (e.g. Cyclin A, B, D and E) (Morgan, 1997; Murray, 2004), some cyclins function
outside of cell cycle regulation. For example, Cyclins C, H and K play roles in
transcriptional regulation (Akoulitchev et al., 2000; Gopinathan et al., 2011; Lim and
Kaldis, 2013). There are also several highly conserved cyclins with unknown functions
such as Cyclin Y. Cyclin Y is the second most highly conserved member of the cyclin
protein superfamily in metazoans after Cyclin C (Liu and Finley Jr, 2010), which
suggests an important conserved cellular function. Yet Cyclin Y’s function remains
poorly characterized. Our lab has previously shown in Drosophila that a Cyclin Y null
mutant is lethal (Liu and Finley Jr, 2010). Cell culture studies suggest that Cyclin Y,
localized to the cell membrane by myristoylation, is required for phosphorylation and
activation of the Wingless (Wg) receptor (Davidson et al., 2009). To study the Cyclin Y
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functions in vivo, I performed a tissue wide screen in Drosophila melanogaster by
targeting CycY with a short hairpin RNA (shRNA) in 31 different tissues using the
Gal4/UAS binary system. The screen suggested that expression of the CycY shRNA
in specific tissue patterns, including the nervous system and the gut, caused larval
lethality and other developmental defects. In addition, other phenotypes were
discovered in the screen in adult flies. Interestingly, expression of the CycY shRNA in
imaginal discs resulted in bent legs and blistered wings. This is an unexpected
phenotype if Cyclin Y functions exclusively in the canonical wingless pathway.
Expression of a myristoylation defective, non-membrane localized Cyclin Y from a
transgene could partially suppress the shRNA-generated wing blister phenotype, and
fully rescue a CycY deletion mutant, which also supports a Cyclin Y function outside
the canonical wingless pathway. Bent legs and blistered wings were previously seen
in mutants of genes in the cell adhesion and focal adhesion pathways (Brown, 1993;
Brown, 2000; Brown et al., 2000; Chen et al., 2005). The Rho pathway is one of the
main pathways that control focal adhesion (Huveneers and Danen, 2009). I tested for
genetic interactions between Cyclin Y and members of the Rho pathway.
Overexpression of a positive regulator of the Rho pathway, LIMK1, suppressed the
wing blister caused by the CycY shRNA. This suggests that Cyclin Y has a
cooperative function with and is epistatic to LIMK1 in cell adhesion in the wing discs.
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1.2. Cyclin Y
Drosophila Cyclin Y was first identified in a yeast two-hybrid screen by Stanyon
and colleagues (Stanyon et al., 2004). That study focused on the protein interaction
map of cell cycle regulators. One of the baits in the screen was Eip63E, also known as
Cdk14. One of the Eip63E interactors identified was CG14939, which was later
renamed Cyclin Y due to its sequence similarity with human Cyclin Y (CCNY) (Liu and
Finley Jr, 2010). Drosophila CycY encodes a protein with 406 amino acid residues.
The Cyclin box is located between regions 205 and 328. Cyclin Y is the second most
highly conserved cyclin in metazoans after Cyclin C. This high evolutionary
conservation suggests essential functions (Liu and Finley Jr, 2010).
Our lab set out to determine the functions of Cyclin Y using the Drosophila
model organism (Liu and Finley Jr, 2010). Previous studies in our lab showed that
homozygous deletion of CycY in Drosophila results in delayed larval growth and pupal
lethality (Liu and Finley Jr, 2010). Lethality could be rescued by a genomic CycY
transgene (Liu and Finley Jr, 2010). When maternal CycY is also deleted, 99.6% of
the CycY null embryos fail to hatch, which demonstrates a requirement for CycY in
embryogenesis (Liu and Finley Jr, 2010). It also suggests that the reason homozygous
CycY null flies could develop through puparation is due to the perdurance of maternal
Cyclin Y and/or downstream products till these stages. Although the CycY null lethality
emphasizes the essential function of Cyclin Y in development, it masks the chance to
detect phenotypes that might serve as clues to the specific pathways that require
Cyclin Y. The tissue wide screen for Cyclin Y that I carried out in this study was
designed to overcome this issue by targeting Cyclin Y in specific tissue patterns.
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1.2.1 Cyclin Y’s Cdk partners:
Several lines of evidence suggest that in Drosophila, Cdk14 is a putative cdk
partner for Cyclin Y (Liu and Finley Jr, 2010; Stanyon et al., 2004). First, a yeast twohybrid screen showed that Drosophila Cdk14 binds to Drosophila Cyclin Y (Stanyon et
al., 2004). Second, the specificity of the Cyclin Y-Cdk14 interaction was further tested
through yeast two-hybrid and co-affinity purification (Co-AP) in Drosophila cultured
cells (Liu and Finley Jr, 2010). Third, Cdk14 loss of function phenocopies the Cyclin Y
null (Liu and Finley Jr, 2010). Fourth, either knockdown of Cdk14 or Cyclin Y leads to
a decreased LRP6 (Arrow) phosphorylation in Drosophila S2R+ cells at Sp1490
(Davidson et al., 2009). Fifth, in Human, CDK14 (PFTK1) and CDK16 (PCTAIRE1) are
putative Cyclin Y (CCNY) partners as demonstrated through yeast two-hybrid and coAP (Jiang et al., 2009; Mikolcevic et al., 2012). Drosophila has no Cdk16 (Liu et al.,
2010). As for C. elegans, PCT-1, a Cdk16 orthologue, was shown to bind to Cyclin Y
(CYY-1) through a pull-down experiment (Ou et al., 2010). An in vitro kinase assay
shows that the PCT-1 kinase activity is dependent on the concentration of the CYY-1.
As the Cyclin Y concentration increases, PCT-1 kinase activity increases (Ou et al.,
2010). Cdk5 is also proposed as a potential Cyclin Y cdk partner. An in vitro kinase
assay, shows that the Cyclin Y concentration affects the Cdk5 kinase activity (Ou et
al., 2010). As the Cyclin Y concentration increases, the Cdk5 kinase activity increases
(Ou et al., 2010).
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1.2.2. Cyclin Y and the canonical Wingless pathway:
Cyclin Y has been linked to the canonical Wingless pathway (Davidson et al.,
2009). In Drosophila S2R+ cells, Davidson and colleagues (Davidson et al., 2009)
show that knockdown of Cyclin Y and/or its cdk partner, Cdk14 results in decreased
phosphorylation of the Wg co-receptor, Arrow at S1490. Knockdown of Cdk14 or CycY
in S2R+ cells expressing constitutively active human Wg co-receptor, LRP6,
decreases Wingless signaling when measured by a Wnt activity reporter assay
(TOPFLASH assay). In Xenopus embryos, knockdown of Cyclin Y in addition to the
Cyclin Y like-1 gene using morpholinos results in decreased LRP6 phosphorylation at
S1490 and decreased Wnt signaling as tested with the TOPFLASH reporter assay.
This decrease in LRP6 phosphorylation could be rescued by injection of human CCNY
mRNA. In addition, Xenopus embryos treated with CycY morpholinos are anteriorized,
which is a characteristic phenotype of reduced Wnt signaling as well as LRP6
knockdown. In human embryonic kidney cells, Davidson and colleagues (Davidson et
al., 2009) show a protein-protein interaction between LRP6 and Cyclin Y using co-AP.
This interaction is compromised when the wild type Cyclin Y is replaced by a nonmembrane localized, myristoylation defective G2A Cyclin Y. The G2A Cyclin Y also
results in a decreased S1490 phosphorylation of LRP6 compared to the wild type
Cyclin Y. In nocodazole synchronized HEK293T cells, both CCNY and PFTK1
expression is enriched in the G2/M phase when LRP6 phosphorylation at S1490 is
also enriched (Davidson et al., 2009). Put together, Davidson and colleagues
(Davidson et al., 2009) conclude that Cyclin Y is required for membrane recruitment
and activation of Cdk14, which in turn phosphorylates and activates LRP6 (Arrow).
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LRP6 activation results in priming and activation of the canonical Wnt signaling
pathway (Davidson et al., 2009). A role for Cyclin Y in the Drosophila Wg pathway in
vivo has not been tested. In addition, in Drosophila, defects in the Wingless pathway
are associated with known phenotypes such as the loss of one or both wings
(Bejsovec, 2006; Sharma and Chopra, 1976). Yet CycY null escapers and pharates do
not phenocopy Wingless pathway mutants; e.g., they show no wing loss (Liu and
Finley Jr, 2010). These findings led us to question whether Cyclin Y functions in the
canonical wingless pathway or other pathways in vivo in Drosophila (Liu et al., 2010).
In this study I addressed this question by knocking down arrow in some of the same
tissue patterns that give CycY specific knockdown phenotypes and comparing the two
sets of phenotypes.

1.2.3. Cyclin Y and myristoylation:
In human cell lines, Cyclin Y is tethered to the cell membrane through Nterminal myristoylation (Davidson et al., 2009; Jiang et al., 2009). The myristoylation
signal sequence is required for the binding of Cyclin Y and Cdk14 to LRP6 in
HEK293T cells and for maximal LRP6 phosphorylation at S1490 [7]. The
myristoylation signal is conserved in Drosophila Cyclin Y (Liu and Finley Jr, 2010),
which strongly suggests a cell membrane localization of Cyclin Y in Drosophila as
well. Our lab has previously developed an N-terminally Myc-tagged Cyclin Y that was
shown to localize mainly in the cytoplasm (Liu, 2010). This is probably because the Nterminal Myc-tag disrupts Cyclin Y myristoylation (Liu, 2010). Interestingly, Myc-Cyclin
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Y successfully rescues CycY null lethality (Liu and Finley Jr, 2010). This led us to
question the importance of Cyclin Y membrane localization for its functions and
supported our hypothesis that maybe Cyclin Y has functions outside the canonical
Wingless pathway (Liu et al., 2010). In this study I developed C-terminally HA or YFPtagged Cyclin Y transgenes to study the Cyclin Y subcellular localization in Drosophila
and I confirmed its putative conserved cell membrane localization. I also developed a
myristoylation defective C-terminally YFP-tagged CycY transgene. This was used to
detect whether the membrane localization of Cyclin Y is essential for its function by
testing whether the myristoylation defective Cyclin Y could rescue the CycY null or
RNAi phenotypes as efficiently as the wild type Cyclin Y.

1.2.4. Cyclin Y in C. elegans.
In C. elegans, a CYY-1 null shows mislocalization of the presynaptic
components (RAB3, SYD-2, SNB-1 and SNG-1) to the dendrites of some motor
neurons. Notably, CYY-1 null animals also have smaller brood sizes (Ou et al., 2010).
Double mutants with p35 or Cdk5 result in a significant increase in this mislocalization
as well as paralyzed worms, which strongly suggests that Cyclin Y and Cdk16 act in a
parallel pathway to p35 and Cdk5. This study also shows that Cyclin Y binds to and
activates Cdk16 to help localize the presynaptic components. While the presence of
Cyclin Y is essential for the Cdk16 function, the opposite is not true. Overexpression
of Cyclin Y could significantly rescue the mislocalization defect produced by the Cdk16
knockout. This indicates that Cyclin Y also acts in a mechanism that does not require
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Cdk16 to localize the presynaptic components. Since Cdk5 and Cdk16 are closely
related, Ou and colleagues (Ou et al., 2010) hypothesize that Cdk5 could be the other
Cyclin Y partner for this function. Indeed, a functional Cdk5 transgene could only
marginally rescue the Cyclin Y mutants, indicating that Cyclin Y is required for some
aspects of the Cdk5 function. Also overexpression of the same Cyclin Y that could
rescue the Cdk16 mutant could not rescue the Cdk16-Cdk5 or Cdk16-p35 double
mutant. This indicates that the presence of both p35 and Cdk5 together is essential for
the Cdk16 independent Cyclin Y function in presynaptic component localization (Ou et
al., 2010). Finally they show that Cdk5 kinase activity increases in the presence of
CYY-1 in an in vitro kinase assay (Ou et al., 2010). Further investigation reveals that
CYY-1 and/or Cdk5 mutants shows significantly increased retrograde transport. Loss
of function of either the dynein complex components, DHC-1 or NUD-2 rescues the
presynaptic component mislocalization due to PCT-1 or Cdk5 loss of function. This
suggested that PCT-1 and Cdk5 are upstream to DHC-1 or NUD-2 and that PCT-1
and Cdk5 might function in the inhibition of the cytoplasmic dynein complex. CYY-1
nulls also show accumulation of presynaptic vesicles in specific motor neurons, which
suggests a role for Cyclin Y in synapse elimination and synaptic remodeling (Park et
al., 2011). Consistently, the Drosophila CycY mRNA is most highly expressed in the
nervous system (Chintapalli et al., 2007). This raises the possibility that perhaps one
reason the CycY null Drosophila die is due to defects in the nervous system.
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1.2.5. Cyclin Y in human disease.
The human Cyclin Y gene (CCNY) is linked to several disease states. Genome
wide association studies reveal a SNP in CCNY that is associated with two
inflammatory bowel disease subphenotypes, Crohn’s disease and ulcerative colitis
(Franke et al., 2008; Waterman et al., 2011).

Cyclin Y is also upregulated in

metastatic colorectal cancer cells (Ying-Tao et al., 2005). Cyclin Y was also found to
be upregulated in two other cancer types, non-small-cell lung cancer (Yue et al., 2011)
and glioma (Xu et al., 2010). More importantly, Cyclin Y’s expression level impacts the
growth rate of the tumor cells in xenografts. Cyclin Y knockdown leads to decreased
cell proliferation and smaller tumor sizes compared to the no knockdown populations
(Xu et al., 2010; Yue et al., 2011).

1.2.6. Cyclin Y degradation through ubiquitination:
In HEK293T cells, human Cyclin Y is shown to be autoregulated by the Cyclin
Y/Cdk14 complex (Li et al., 2014). Binding and activation of Cyclin Y to Cdk14 further
results in its phosphorylation at serine 71 and serine 73. This results in the formation
of a phosphor-degron, which allows recognition by the SCF ubiquitin ligase complex
and Cyclin Y degradation through the ubiquitin proteasome pathway. This degradation
is dependent on the presence of Cdk14 and its kinase activity since knockdown of
Cdk14 results in Cyclin Y stability. Overexpression of a kinase defective Cdk14D256A
also shows decreased Cyclin Y ubiquitin degradation compared to the overexpression
of a wild type Cdk14 (Li et al., 2014).
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1.3. Project outline:

In this project, I studied the functions of Cyclin Y using Drosophila as a model
organism. Drosophila melanogaster is hundreds of millions of years distant from
human in the phylogenetic tree. At the same time, the Drosophila Cyclin Y protein has
a 52% sequence identity with human Cyclin Y (Liu and Finley Jr, 2010). The high
conservation of the protein between species strongly suggests an essential conserved
biological function for Cyclin Y. It also suggests that Drosophila melanogaster is a
suitable model organism for this study of the conserved biological functions of Cyclin
Y. In addition, Drosophila is a well-established model organism that provides a
powerful in vivo system with a very short life cycle, where an array of state-of-the-art
genetic and molecular techniques can be easily applied.
In this study, I used in-vivo phenotypic analysis and localization studies to study
the Drosophila Cyclin Y functions. I addressed the following specific aims.
Aim 1: To test the hypothesis that Cyclin Y is involved in molecular pathways outside
of or in addition to phosphorylation and activation of Arrow in the canonical wingless
pathway in Drosophila.
1.a. To identify specific biological systems and putative molecular pathways that
require Cyclin Y by screening for tissue-specific Cyclin Y loss of function phenotypes
using RNAi-mediated knockdown of Cyclin Y in specific tissues. To accomplish this I
expressed a CycY short hairpin RNA (shRNA) (Ni et al., 2011) in specific tissues by
using the Gal4/UAS system (Brand and Perrimon, 1993). I screened for lethality in

11

embryos, larvae, pupae and adults. I also characterized other abnormal phenotypes.
1.b: To determine biological systems where Cyclin Y functions outside the canonical
wingless pathway. To accomplish this, I knocked down arrow using a dsRNA in the
same tissue patterns that resulted in abnormal phenotypes in the CycY knockdown
screen and compared the phenotypes (Ni et al., 2008).
Aim 2: To test the hypothesis that Cyclin Y does not require membrane localization for
some of its functions by mutating the myristoylation sequence at the N-terminus of
Cyclin Y and testing whether the myristoylation defective mutant can complement
CycY knockdown phenotypes. Cyclin Y and the myristoylation-defective Cyclin Y were
YFP tagged to trace and confirm the Cyclin Y localization.
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CHAPTER 2

A TISSUE-WIDE RNAi SCREEN TO IDENTIFY BIOLOGICAL PROCESSES AND
MOLECULAR PATHWAYS THAT REQUIRE CYCLIN Y

2.1. INTRODUCTION
Previous studies in our lab showed that homozygous deletion of CycY in
Drosophila resulted in delayed growth and lethality mostly by the pupal stage (Liu and
Finley Jr, 2010). This emphasizes the essential function of Cyclin Y in development
and survival. But the early stage lethality of the CycY null Drosophila masks the
chance to detect many phenotypes in adult flies that might serve as clues to the
specific biological functions and molecular pathways that are defective in the absence
of Cyclin Y such as phenotypes in the wings, eyes as well as any detectable
behavioral defects. To discover Cyclin Y phenotypes, I carried out a tissue-wide,
tissue-specific knockdown screen for CycY. In the screen I used RNA interference
(RNAi) and the Gal4/UAS binary method developed by Brand and Perrimon for
targeted gene expression in Drosophila (Brand and Perrimon, 1993). Gal4 is a
transcription regulator in Saccharomyces cerevisiae where it binds to an upstream
activating sequence (UAS) of several genes (e.g. GAL1 and GAL10) to regulate them
(Laughon et al., 1984; Laughon and Gesteland, 1984). In the Gal4/UAS system, the
Gal4 is expressed in Drosophila by using a specific promoter. This promoter can be
specific to a certain tissue or stage. For example, the elav promoter is specific to the
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nervous system (Green, 2010) and can be used to express Gal4 in the nervous
system. A gene of interest, such as a double stranded RNA (dsRNA) or short hairpin
RNA (shRNA), can be expressed in the same pattern by linking it to a UAS.
In this screen, by crossing individual fly strains that each express Gal4 under
the influence of a different tissue-specific gene promoter (“Gal4 driver lines”), with flies
that have UAS-shRNA for CycY, progeny with both Gal4 and the UAS were obtained.
These progeny should experience tissue-specific knockdown of CycY by RNA
interference. I used 31 different Gal4 lines. I monitored and quantified lethality in each
of the four stages of Drosophila development (embryos, larvae, pupae and adults).
For the same reasons I mentioned above, Dongemi Liu (Liu, 2010) developed a
dsRNA against CycY and tested for knockdown phenotypes using the UAS/Gal4
system. She showed that expression of the dsRNA ubiquitously with Act-Gal4 resulted
in lethality at developmental times similar to the zygotic CycY null (Liu, 2010).
Expression of the dsRNA in posterior wing discs with the en-Gal4 driver resulted in
decreased posterior wing area, possibly due to reduced cell proliferation, and this
phenotype could be suppressed by expression of a CycY transgene. Expression of the
dsRNA in the 69B-Gal4 pattern resulted in extra wing vein formation (Liu, 2010). In
this study, I made a couple of modifications to the previous one. First, I used a short
hairpin RNA (shRNA) against CycY that was developed by the pTRiP project (Ni et al.,
2011). This was the lately developed RNAi system at the time when I started this
study. I used the shRNA because the pTRiP shRNA targets only 21 bp, which are
designed to be highly specific to the target gene (Ni et al., 2011). This decreases the
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possibility of off-target gene knockdown (Ni et al., 2011), which is higher with dsRNA
that are designed to target hundreds of bp of a gene. Second, I expanded the tissue
specific CycY knockdown study to increase its spatial and temporal details. This was
achieved by increasing the number and variety of specific tissues being targeted using
31 Gal4 lines (Appendix A) and also by carefully tracking lethality in each stage of
development in each of the 31 Gal4 lines as they transitioned from embryos to larvae
to pupae to adult flies. The detailed analysis increased our chances to detect tissues
that require Cyclin Y for survival. It also increased our chance to detect phenotypes
that could guide us to putative biological functions and molecular pathways that
require Cyclin Y. In this chapter, I discuss the detailed setup of the tissue-wide, tissuespecific screen and its results.
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2.2. MATERIALS AND METHODS
2.2.1. Fly stocks
All fly stocks were maintained in vials containing standard cornmeal molasses
medium and raised at 25°C unless otherwise stated. A fly line (y1 sc* v1;
p(TRiP.HMS00974) attP2)) from the Harvard Transgenic RNA Interference Project
(TRiP) expressing a CycY shRNA from a UAS (Ni et al., 2011) was obtained from the
Bloomington stock center (BDSC# 34009, Finley lab stock # 918). TRiP.HMS00974 is
based on the VALIUM20 vector and contains a 21bp shRNA targeting CycY (Hairpin
ID: SH01655.N) Top Oligo: TGCGATCATCACGCTA GTCTA, Bottom Oligo: TAGACT
AGCGTGATGATCGCA (Ni et al., 2011). An shRNA against mCherry was used as a
control. This control fly line (y1 sc* v1; P(VALIUM20-mCherry)attP2) was obtained
from the same Valium 20 collection (BDSC# 35785, Finley lab stock # 1016) and has
the same insertion site and genetic background as that of the CycY shRNA line. The
Gal4 lines used in this study and their expression patterns are listed in appendix A. To
verify the Gal-4 lines used in this study I crossed each with a line containing UAS
driving a green fluorescent protein (GFP) (sp/Cyo; UAS-GFP/UAS-GFP) (Source:
Bloomington Stock # 1521, Finley lab stock # 443) and tested for GFP expression in
all F1 larvae. L3 larvae of F1 were collected and dissected in PBS under a fluorescent
dissection microscope. The expression patterns of the Gal4 lines are reported in
appendix A.
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2.2.2. Tissue-wide, tissue specific screen for Cyclin Y in vivo:
2.2.2.1. Screening Scheme:

Figure 2-1: A scheme of the approach of the tissue-wide CycY knockdown
screen.
2.2.2.2. Tissue-wide CycY knockdown screen:
The tissue-wide knockdown screen was accomplished by using RNA
interference (RNAi) and the Gal4/UAS binary method, developed by Brand and
Perrimon for targeted gene expression in Drosophila (Brand and Perrimon, 1993).
Age matched 1-10 day old virgin female y1 sc* v1; +/+; UAS-shRNA attP2 expressing
shRNA targeting CycY or mCherry were mated with Gal4 driver lines with
homozygous Gal4 on chromosome 1 (xx-Gal4; +/+; +/+), 2 (xx-Gal4; +/+), or 3 (+/+;
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xx-Gal4), where xx is the particular Gal4 driver (Appendix A). In the case of Gal4
chromosomes that are homozygous lethal (Appendix A), the shRNA lines were mated
with xx-Gal4/Act-GFP, Cyo or +/+; xx-Gal4/Act-GFP, TM3, Ser, and non-GFP F1 were
scored. For each tissue-specific knockdown, I quantified the fraction of embryos,
larvae and pupae that progressed to the next stage. I also quantified survival and the
presence of any gross abnormalities in adults; specifically, I looked for obvious defects
in the eye, wing, legs, abdomen & mouth. Images were obtained for gross phenotypes
using a Leica MZ 16FC stereomicroscope and Spot RT3™ camera. The whole
experiment was done at 27°C. The screen was performed in independent triplicates,
where new parent flies were used each time. The test and control crosses were done
at the same time.
To determine lethality, parent flies were allowed to lay eggs in chambers placed
on apple juice agar plates overnight. After one day, first instar larvae were transferred
to individual regular fly food vials. After 3 days, the number of unhatched eggs in each
apple juice agar plate was recorded and the percentage embryonic lethality for the test
and control groups was calculated from the fraction of laid eggs that remained.
Embryonic lethality was not monitored for Gal4 lines that were homozygous lethal due
to the inability to differentiate GFP positive from GFP negative embryos. To calculate
larval lethality, pupae in the vials, where the first instar larvae were transferred, were
counted after 6-8 days from the first instar larval transfer. The percentage larval
lethality for the test and control groups was calculated as the fraction of picked larvae
that failed to become pupae. Likewise, the percentage pupal lethality for the test and
control groups was calculated from the fraction of pupae that remained uneclosed 11-

18

12 days after the first instar larval transfer. In each case the mean percentage lethality
and standard error of the mean were calculated from triplicate matings and plotted.

2.2.2.3. Adult survival analysis:
Eclosed adult males and females (0-1 days old) were transferred to fresh
regular fly food vials and monitored for longevity for the first 5 days and then once
every five days until they all died. The flies were transferred to new vials every two
days for the first 4 days, once on day 5 and then once every five days for the length of
the experiments. To score the dead flies, for the first 5 days, the flies that were stuck
to the vials and also not moving were counted as dead. Then every 5 days, the living
flies were counted and transferred to fresh fly food. For Gal4 lines that are
homozygous lethal (Appendix A) the Gal4 chromosomes were balanced over ActGFP, Cyo or Act-GFP, TM3, Ser and non-GFP L1 larvae were selected for analysis.
Wilcoxon Rank-Sum test was used to determine the Gal4 expression patterns that
gave statistically lower median adult survival times in the CycY shRNA groups as
compared to the mCherry shRNA groups. Gal4 lines with p values <0.05 in each of
the triplicates were considered CycY shRNA-dependent defective in survival.

2.2.3. Construction of shRNA resistant CycY transgenic flies:
I expressed shRNA-resistant CycY cDNA using plasmids pTWV-attB and pTWH-attB
(Figure 2-2).
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2.2.3.1.

Primers and plasmids:

Primers and plasmids designed and used in this chapter are listed in Appendix B and
C respectively.

2.2.3.2.

Construction of Plasmids pUASt-Gateway-3xHA-attB (pTWH-attB) and
pUASt-Gateway-Venus-attB (pTWV-attB):

The plasmids were constructed by first amplifying the Gateway cassette along
with the Venus (YFP) tag or the 3xHA tag from pTWV (UASt / Gateway vector-Venus /
C-terminus) and pTWH (UASt / Gateway-3xHA / C-terminus) (Murphy, 2003),
respectively using Primers NG21 (5’ GAGAACTCTGAATAGGCAATTGGGAAT), and
NG22 (5’ CCTTCACAAAGATCCTCTAGCTTACGT). The NG21 primer introduced a
G to C mutation to make an Mfe1 restriction site. Purified PCR products (the Gateway
casette-Venus or the Gateway casette-3xHA) were digested using Mfe1 and Nhe1
and inserted into pUASt-attB (Bischof et al., 2007) cut with EcoR1 and Xba1. Inserts
were verified using PCR. The anticipated plasmid sequences are listed in appendix D
(pTWH-attB) and appendix E (pTWV-attB).
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Figure 2-2. A scheme of the construction plan of the two plasmids pUAStGateway-HA attB (pTWH-attB) and pUASt-Gateway-Venus attB (pTWV-attB) from
the pUASt-attB vector and the murphy vectors pTWH and pTWV respectively.
2.2.3.3. Construction of the shRNA resistant CycY ORF:
The shRNA against CycY targets nucleotides 750 to 770 of the CycY ORF. I
used site directed mutagenesis to introduce two silent point mutations in nucleotides
759 (C ! A) and 762 (G !C) of the CycY ORF using primers NG15 (5’
GCGATCATAACCCTAGTCTACC)

and

NG16

(5’

GGTAGACTAGGGTTATGA

TCGC). The CycY ORF was amplified from a CycY cDNA clone obtained from the
Drosophila Genome Collection series 1 (DGC1) distributed by the Drosophila Genome
Resource Center (DGRC) (Clone ID: LD31675). In separate PCR reactions, the CycY
ORF from position 1 to position 772 was amplified with primers NG11 (5’
GGGGACAAGTTTGTACAAAAAAGCAGGCTCCGGCAAAATGGGCAACAAG)

and
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NG16, while the CycY ORF from position 751 to the stop codon was amplified with
primers NG15 and NG12 (5’ GGGGACCACTTTGTACAAGAAAGCTGGGTCCGAT
AGTATGGCCACGCTG). NG11 added a Kozak sequence to the 5’ end of the CycY
ORF as well as the attB1 sequence for Gateway cloning. NG12 removed the stop
codon, so that Cyclin Y could be tagged at the C-terminus and added the attB2
sequence to the CycY ORF 3’ end for Gateway cloning. Extension overlap was used
to fuse the two PCR products. Using the Gateway cloning BP reaction, the ORF was
inserted into pDonr221 (Invitrogen) to make CycY-2pt-pDonr221 and the inserts were
sequence verified. The shRNA resistant CycY ORF (CycY-2pt) was transferred into
the new plasmids, pTWH-attB and pTWV-attB using the Gateway cloning LR reaction.
The new plasmids containing CycY-2pt-3xHA or CycY-2pt-YFP was inserted into the
P2 insertion site on chromosome 3 by embryo injection (Genetic Services, Inc.)

2.2.4. Phenotype specificity experiments (rescue experiments):
To test whether the phenotypes obtained from the screen result from CycY
knockdown, I set out to rescue them using shRNA resistant CycY transgenic flies (HA
and YFP). Fly strains with the Gal4 lines and the shRNA resistant CycY ORF were
constructed (genotype: xx-Gal4; CycY-2pt-HA or xx-Gal4; CycY-2pt-YFP). These flies
were crossed with the y1 sc* v1; +/+; UAS-shRNA attP2 flies for CycY or for mCherry
as a control.
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2.2.5. Single wing analysis:
Single wings were dissected from adult female flies, mounted with light mineral
oil on glass slides and made flat with the coverslips and imaged. The wings were
examined using the Leica MZ 16FC stereomicroscope. Images of the single wings
were taken using the Spot RT3™ camera. In the case of engrailed driven posterior
wing blisters, Image J software was used to measure the area of the wing blisters as
well as the area of the posterior portions of the wings to quantify the extent of the wing
blister.
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RESULTS
2.3.1. Expression of a CycY shRNA in specific tissue patterns causes larval
lethality and other developmental defects
Previous studies showed that CycY null flies arrest before reaching the adult stage
and that CycY expression is required throughout development (Liu and Finley Jr,
2010). To identify tissue-specific requirements for Cyclin Y, I used the Gal4/UAS
system and RNAi to knock down expression of CycY in a wide range of tissues. I
expressed an shRNA targeting CycY (Ni et al., 2011) in 31 different Gal4 expression
patterns, including the nervous system, muscle, gut, circulating cells, imaginal discs,
and others. The Gal4 expression patterns were verified by examining UAS-GFP
expression in L3 larvae (Appendix A).
For each Gal4 line I scored lethality at each developmental stage for the shRNAexpressing strain relative to age-matched controls expressing an shRNA for mCherry
(Methods). As expected from the lethality of a CycY null (Liu and Finley Jr, 2010),
ubiquitous expression of the CycY shRNA using Act5C-Gal4 was lethal, where 100%
of the flies died by the larval stage (Figure 2-4). In contrast, expression of the shRNA
in most of the specific tissue patterns resulted in no significant lethality or overt
phenotypes, suggesting that Cyclin Y may be required only in specific tissues for
survival or development. Expression of the CycY shRNA in seven specific patterns led
to significant early stage lethality (Table 2-1). For most of these, lethality occurred in
the larval stage. Expression of the shRNA in three of these patterns (24B-Gal4, ptcGal4, and 69B-Gal4) led to nearly complete larval lethality, while two of these patterns
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(ptc-Gal4 and 69B-Gal4) also led to significant embryonic lethality. Like Act-5C-Gal4,
24B-Gal4 driven CycY knockdown resulted in death at the first instar larval stage. All
first instar larvae showed body rigidity and immobility before dying. Most of them were
bent in the head region. 24B-Gal4 drives expression in the mesoderm, larval muscles,
nervous system, and trachea (Osterwalder et al., 2004; Staehling-Hampton et al.,
1994; Suster et al., 2003) (Appendix A). Both ptc-Gal4 and 69B-Gal4 patterns include
expression in the nervous system, the gut, salivary glands and imaginal discs
(Appendix A) (Brand, 1997; Gettings et al., 2010; Monastirioti, 2003; Page, 2002).
69B-Gal4 is also expressed in patches of the epidermis (Staehling-Hampton et al.,
1994) (Appendix A). Two patterns (en-Gal4 and c601-Gal4) led to 35-60% larval
lethality, and a significant fraction of the survivors arrested as pupae. En-Gal4 and
c601-Gal4 drive expression in the gut. En-Gal4 also drives expression in the posterior
wing discs and some parts of the nervous system. C601-Gal4 also drives expression
in the salivary glands (Gettings et al., 2010; Harrison et al., 1995; Johnson et al.,
1995; Sozen et al., 1997) (Appendix A). Mild but statistically significant larval lethality
was seen with cg-Gal4 and pnr-Gal4 driven CycY shRNA. Cg-Gal4 drives expression
in hemocytes, fat body and lymph glands (Hennig et al., 2006) (Appendix A). Pnr-Gal4
drives expression in denticle belts, salivary glands, and imaginal discs (Calleja et al.,
1996; Giagtzoglou et al., 2005) (Appendix A). Only one expression pattern (ser-Gal4)
led to significant lethality starting only at the pupal stages. Ser-Gal4 drives expression
in the nervous system and imaginal discs (Fleming et al., 1997; Hukriede et al., 1997)
(Figures 2-3, 2-4 and 2-5, Table 2-1 and Appendix A).
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Expression of the CycY shRNA in some specific patterns led to significant adult
survival defects (Table 2-1, Figure 2-6 and Appendix F and G). The survival defects
were observed in both males and females with 48Y-Gal4 but primarily in females with
D42-Gal4, Aug21-Gal4, and ELAV-Gal4. Expression of the CycY shRNA in the 112AGal4 pattern led to survival defects specifically in males. Elav-Gal4 specifically drives
expression in the nervous system (Lin and Goodman, 1994; Zhan et al., 2004), while
48Y-Gal4 expresses in the nervous system, the gut and parts of the epidermis (Table
2-1) (Martin-Bermudo et al., 1997; Riese et al., 1997; Szuts et al., 1998). 112A-Gal4,
D42-Gal4 and Aug-21-Gal4 also drive expression in the nervous system plus other
tissue patterns, including the gut for 112A-Gal4 the salivary glands for D42-Gal4, and
the corpora allata and larval ring gland for Aug-21-Gal4 (Crowner et al., 2002; Larkin
et al., 1996; Martin-Bermudo et al., 1997; Nitz et al., 2002; Riese et al., 1997; Szuts et
al., 1998; Thummel, 2010; Yeh et al., 1995) (Table 2-1). En-Gal4 and Ser-Gal4 were
only tested in females because almost no male adults emerged. Expression of the
CycY shRNA in the en-Gal4 expression pattern in the females led to survival defects
yet the p-value for one of the triplicates was slightly higher than 0.05 (Appendix F and
G).
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Table 2-1: Summary of the results obtained from the tissue wide CycY
knockdown screen.
Gal4 line

Lethality
E

24B
Elav
Cg
Ser
C601
Pnr

L
100%

P
NA

ND
7.3%
ND

34.7%
14%

50%
8%

112A

Wing blisters.
+++
(♂ & ♀)

48Y
En
Ptc
69B
Act5c

Survival
Defects Other abnormal phenotypes
A
st
NA
Immobile 1 instar larvae that die.
+ (♀)

84.7%
64.3%
ND

61.2%
95.2%
89.6%
100%

NA
NA
NA

NA
NA
NA
+ (♂)

Wing blisters.
Bent legs, locomotion defects,
unflexed wings and probosces.
Wing blisters
st

Immobile 1 instar larvae that die.

D42
+++ (♀)
Aug21
+ (♀)
Lethality is the fraction of live animals that failed to progress from the indicated stage
to the next stage.
E: Embryonic lethality. L: Larval lethality. P: Pupal lethality. A: Adult survival defects.
Blanks indicate no significant lethality or survival defects.
ND = Not done because the Gal4 line is homozygous lethal.
NA = Not applicable due to high percentage lethality of previous stages.
Numbers represent mean percentage lethality of independent triplicates.
+++ p<0.0005; ++ p<0.005; + p<0.05, the highest p-values, in the triplicate survival
analyses, was considered.
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Figure 2-3. Embryonic lethality due to CycY shRNA expression in specific tissue
patterns. The percent of laid eggs that hatched from females expressing the CycY
shRNA or the mCherry shRNA in the Gal4 patterns is indicated. A significant difference
between the CycY shRNA and the mCherry shRNA in the ptc-Gal4 and 69B-Gal4
patterns indicates CycY shRNA-dependent embryonic lethality (*p<0.05). The Gal4 lines
are arranged in ascending order according to their p-values. The x-axis shows the
different Gal4 drivers used in the screen and the y-axis shows the % of eggs that fail to
hatch. Error bars = S.E.M.

28

Figure 2-4. Larval lethality due to CycY shRNA expression in specific tissue
patterns. Expression of CycY shRNA in 8 Gal4 expression patterns (24B-Gal4, Act5CGal4, Ptc-Gal4, En-Gal4, 69B-Gal44, c601-Gal4, cg-Gal4 and pnr-Gal4) led to
significant larval lethality (*p<0.05) compared to the mCherry shRNA control. The Gal4
lines are arranged in ascending order according to their p-values. The x-axis shows the
different Gal4 drivers used in the screen and the y-axis shows the % of larvae that died.
Error bars = S.E.M.
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Figure 2-5. Pupal lethality due to CycY shRNA expression in specific tissue
patterns. Expression of the CycY shRNA in the c601-Gal4 and Ser-Gal4 expression
patterns led to significant pupal lethality compared to the mCherry shRNA control
(*p<0.05). The Gal4 lines are arranged in ascending order according to their p-values.
The x-axis shows the different Gal4 drivers used in the screen and the y-axis shows the
% of pupae that died. Error bars = S.E.M.
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2.3.1.2. Adult flies survival curves in the CycY tissue wide knockdown screen.

Figure 2-6: Adult Survival Defects due to CycY shRNA expression in specific
tissue patterns. Expression of the CycY shRNA in 48Y-Gal4, D42-Gal4, Aug21-Gal4,
ELAV-Gal4 and 112A-Gal4, led to adult survival defects. The blue line represents the
CycY shRNA test group and the red line represents the mCherry shRNA control group.
The x-axis shows the age in days and the y-axis shows the mean percentage living flies
on this day based on three independent experiments.
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In summary, expression of an shRNA targeting CycY in several specific tissue
patterns resulted in larval or pupal lethality or adult survival defects. The Gal4 lines that
caused significant lethality in more than one stage (such as 69B-Gal4 and ptc-Gal4)
suggest a requirement for CycY in those expression patterns during more than one
developmental stage. This is in agreement with previous studies on CycY null flies
where different regimes of heat shock induced expression of a CycY transgene
revealed that Cyclin Y is required in embryos, larvae and pupae, as well as in adults for
survival (Liu and Finley Jr, 2010). A common system being targeted in Gal4 lines that
caused early stage lethality or adult survival defects is the nervous system, suggesting
an important role for Cyclin Y in the nervous system.

2.3.2. Other phenotypes that emerged from the tissue-wide screen:
In addition to monitoring stage lethality in the tissue wide screen, I set out to
identify abnormal phenotypes in the adult flies. The tissue wide CycY knockdown
screen revealed some abnormal phenotypes in the adult flies. Those phenotypes were
monitored and quantified as explained in detail in this section. In addition to their
importance in confirming biological systems that require Cyclin Y, those phenotypes
were useful guides to putative molecular pathways that require Cyclin Y by matching
those phenotypes with phenotypes seen in literature.
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2.3.2.1. Adult flies are underdeveloped and have unflexed limbs upon expression
of the CycY shRNA in the 48Y-Gal4 pattern.
When the CycY shRNA was expressed in the 48Y-Gal4 expression pattern,
many adults were found unable to move. A closer look at the flies showed that they had
bent legs, which impeded them from moving (Figure 2-7). Many of those flies appeared
to have smaller abdomens and unflexed wings and probosces. I found that 83% (+/-9)
of the 48Y-Gal4 driven CycY shRNA adults had bent legs (Fig. 2-7 B). To test whether
this phenotype specifically resulted from knock down of CycY expression, I constructed
an shRNA-resistant CycY-YFP transgene with two point mutations in the shRNA target
sequence (Methods). Expression of this shRNA-resistant CycY-YFP in the 48Y-Gal4
pattern along with the CycY shRNA resulted in a ~4-fold reduction in the fraction of
adults with bent legs (Fig. 2-7 B). This suppression is not due to dilution of Gal4 by the
additional UAS since a UAS-GFP transgene control only mildly suppressed the bent leg
phenotype (Fig. 2-7 B). These results strongly suggest that the bent legs phenotype in
the 48Y-Gal4>CycY shRNA flies are specifically due to CycY knockdown.
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Figure 2-7. Knockdown of CycY in the 48-Y Gal4 expression pattern results in
underdeveloped flies with bent legs, unflexed wings and mouthparts and small
abdomens. A.i. 48Y-Gal4>CycY shRNA fly, underdeveloped and with bent legs. A.ii.
Normal 48Y-Gal4>mCherry shRNA fly. B. Percentage of flies with bent legs (Methods).
CycY shRNA resulted in 83% (+/-9) of flies with bent legs compared to 0% of flies with the
mCherry shRNA. The CycY shRNA bent leg phenotype is partially rescued using shRNAresistant CycY transgenes, CycY-2pt-YFP, where only 24% (+/-4) show bent legs. This
suppression is not due to dilution of Gal4 by the additional UAS since a UAS-GFP
transgene control only mildly suppressed the bent leg phenotype to 65% (+/-1) of the
flies. The x-axis shows the % of flies with bent legs and the y-axis shows the different
genotypes tested in this experiment. Error bars = S.E.M.
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2.3.2.3. Expression of the CycY shRNA in wing imaginal discs causes wing
blisters.
Expression of the CycY shRNA in the posterior portion of wing discs by enGal4 caused a wing blister phenotype in the posterior portion of wings in 100% of the
flies (Figure 2-8). This phenotype was not seen with the mCherry shRNA control.
ShRNA-resistant CycY transgenes expressing HA-tagged or YFP-tagged Cyclin Y in the
same expression pattern significantly reduced the wing blister phenotype severity (Fig.
2-8 B). Although 100% of the flies still had blisters, the average area of the posterior
wing covered by the blister was reduced from 62% to 42% by expression of Cyclin Y-HA
(p=3.78e-9) and to 34% by expression of Cyclin Y-YFP (p=6.03e-15), but was not
significantly reduced by the presence of other UAS transgenes (Fig. 2-8 B). A wing
blister phenotype was also seen when the CycY shRNA was expressed in the distal
portion of the wing using the ser-Gal4 driver (Fig. 2-9). This phenotype was less
penetrant than that driven by en-Gal4; 46% of the ser-Gal4 > CycY shRNA flies had
distal wing blisters, while none of the ser-Gal4 > mCherry shRNA group showed this
phenotype. The fraction of animals with blisters could be significantly reduced by
expression of shRNA-resistant transgenes, Cyclin Y-HA or Cyclin Y-YFP, to 10% (+/-4,
p=3.59e-05) or 3%(+/-2, p=9.01e-07), respectively but not by the presence of additional
UAS transgenes (Fig. 2-9 B). Combined, these results indicate that specific knockdown
of CycY in the wing disc causes wing blisters.
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Figure 2-8. Expression of the CycY shRNA in the posterior wing discs results in
wing blister formation and no wing notching. En-Gal4 driven expression of the CycY
shRNA results in the formation of a blister (A.i) that covers 61.77% (+/- 1.68) of the
posterior area of the wing (B). The mCherry knockdown control shows normal wings
(A.ii). (B) The wing blister phenotype can be suppressed with shRNA-resistant CycY
transgenes: CycY-2pt-HA reduced the blistered area to 42.16% (+/-2.46) (p=3.78e-9),
while CycY-2pt-YFP reduced the blistered area to 34.34% (+/-2.56) (p=6.03e-15). The
x-axis shows the % the posterior wing area that is blistered and the y-axis shows the
different genotypes tested in this experiment. Error bars = S.E.M.
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Figure 2-9. Expression of the CycY shRNA in the distal wing results in blister
formation and no notching. Ser-Gal driven expression of the CycY shRNA results in
the formation of a wing blister, whereas the mCherry shRNA control shows normal
wings (A.ii). (B) The wing blister phenotype can be suppressed with shRNA resistant
CycY transgenes. The CycY-2pt-HA or CycY-2pt-YFP reduced the number of flies with
wing blisters from 46% (+/- 2) with the CycY shRNA alone to 10% (+/- 4, p=3.59e-05) or
3%(+/-2, p=9.01e-07), respectively. The x-axis shows the % of flies with dorsal wing
blisters and the y-axis shows the different genotypes tested in this experiment. Error
bars = S.E.M.
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2.4. DISCUSSION AND CONCLUSIONS
In this chapter, I carried out a tissue-wide, tissue-specific screen using the
Gal4-UAS binary system to discover biological processes and molecular pathways that
require CycY. Our screen showed that expression of a CycY shRNA in several tissue
patterns resulted in lethality in different developmental stages. Lethality occurred in the
larval stage in the majority of the cases. The nervous system was a common tissue
pattern between several Gal4 drivers that showed lethality. The Gal4 drivers 69B-Gal4,
ptc-Gal4, 24B-Gal4, en-Gal4 and ser-Gal4 all express in the nervous system and
caused larval or pupal lethality when driving expression of the CycY shRNA (Table 2-1
and Appendix A). Combined with the fact that CycY is expressed at its highest level in
the larval nervous system relative to other tissues (Murali et al., 2014), these results
suggest that Cyclin Y has important functions in the Drosophila nervous system.
Interestingly, however, expression of the CycY shRNA with the pan-neural driver elavGal4 did not result in significant larval or pupal lethality, though it did decrease adult
viability. This could be explained if elav-Gal4 drives a lower expression level than the
other Gal4 lines. Those findings are consistent with a role for Cyclin Y in the nervous
system that is suggested in a Drosophila large-scale elav-Gal4 driven dsRNA
knockdown study where CycY knockdown using a dsRNA resulted in defects in the
neuromuscular junctions (Valakh et al., 2012). Cyclin Y was also shown to function in
the C. elegans nervous system, specifically in synapse elimination and neural circuit
rewiring (Ou et al., 2010; Park et al., 2011).
Expression of the CycY shRNA in the 48Y-Gal4 expression pattern, which
includes the nervous system, gut, and parts of the epidermis, resulted in
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underdeveloped flies with small abdomens, bent legs, and unflexed wings and
probosces. Many of those flies had locomotion defects, most probably due to the bent
legs. They also had survival defects. While many flies died in the pupal stage, all of the
adult flies died much earlier than the mCherry knockdown flies (Fig. 2-6 and 2-7).
Similar

phenotypes

were

observed

in

CycY

null

escaper

flies,

which

are

underdeveloped and show bent legs and hence locomotion defects. About 50% of
escapers have unflexed wings (n=6) (Liu and Finley 2010 and data not shown). This
supports the conclusion that the phenotypes induced by 48Y-Gal4 driven expression of
the CycY shRNA are Cyclin Y specific.
The screen also indicated that expression of a CycY shRNA in wing discs
results in wing blisters (Fig 2-8 and 2-9). This phenotype occurs due to failure of cell
adhesion between the two epithelial sheets that form the wing blades and their basal
membrane. The hemolymph collects between the epithelial layers and forms the wing
blister. The excess hemolymph is eventually absorbed into the body resulting in a
crumpled wing appearance (Brown, 1993; Brown, 2000; Brown et al., 2000). Expression
of the CycY shRNA in wing discs with en-Gal4 and ser-Gal4 resulted in variable levels
of wing blisters that could be partially suppressed with RNAi-resistant CycY transgenes.
Wing blistering is an unexpected phenotype if the main role of Cyclin Y is to recruit
Cdk14 to the cell membrane to activate the Wg co-receptor Arrow, as suggested from
cell culture studies (Davidson et al., 2009). This finding supports our hypothesis that
Cyclin Y has functions outside of the wingless pathway.
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CHAPTER 3

CYCLIN Y SUBCELLULAR LOCALIZATION IN DROSOPHILA

3.1 INTRODUCTION
In human cell lines, Cyclin Y is tethered to the cell membrane through
myristoylation at its N-terminus (Davidson et al., 2009; Jiang et al., 2009). Myristoylation
is a co-translational or post-translational modification where myristate, a 14-carbon
saturated fatty acid, is attached to the N-terminal glycine (Maurer-Stroh et al., 2002;
Wright Mh Fau - Heal et al.). Myristoylation is catalyzed by N-myristoyltransferase
(NMT) where the N-terminal glycine is essential for this chemical reaction (Maurer-Stroh
et al., 2002; Wright Mh Fau - Heal et al.). Therefore, a G2A mutation in human Cyclin Y
results in a myristoylation defective, non-membranous Cyclin Y (Davidson et al., 2009;
Jiang et al., 2009). The myristoylation signal sequence is conserved in Drosophila
Cyclin Y (Liu and Finley Jr, 2010), which led us to expect that Cyclin Y is membrane
localized in Drosophila as well. In this chapter, using the Cyclin Y-YFP transgene and
transgenic flies, I showed that Cyclin Y is indeed localized at the cell membrane in
S2R+ and S2 cells as well as in vivo in wing imaginal discs.
Our lab has previously developed an N-terminally Myc-tagged Cyclin Y that was
shown to localize mainly in the cytoplasm (Liu, 2010). The cytoplasmic localization of
Myc-Cyclin Y is probably due to disruption of the myristoylation sequence by the Nterminal Myc-tag. Interestingly, Myc-Cyclin Y partially rescues CycY null lethality (Liu
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and Finley Jr, 2010). This suggests that some of the Cyclin Y functions do not require
the Cyclin Y membrane localization (Liu, 2010).
In this chapter, I investigated the requirement of Cyclin Y membrane localization
for Cyclin Y functions, specifically in the cell adhesion function in the wing discs. This
was accomplished by testing the ability of shRNA resistant YFP-tagged Cyclin Y, that
either contain or lack the myristoylation signal, to complement CycY mutants or
suppress CycY shRNA phenotypes. Consistent with the N-terminally tagged Myc-Cyclin
Y results, some CycY shRNA phenotypes, such as the wing blisters were suppressed
by the myristoylation defective Cyclin Y, which supports that membrane localization, is
not required for some Cyclin Y functions.
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3.2. MATERIALS AND METHODS
3.2.1. Construction of the shRNA resistant CycY-G2A-2pt-YFP fly strain.
The CycY-G2A-2pt plasmid was made by PCR amplifying CycY-2pt from CycY2pt-pDonr221

(Chapter

2)

using

primers

NG12

and

NG17

(5’

GGCAAAATGGCCAACAAGAAC), which introduces the G2A mutation. An attB1 was
added

to

the

5’

end

of

the

PCR

product

by

amplifying

with

DM1

(5’

GGGGACAAGTTTGTACAAAAAAGCAGGCT) and NG12 and the product was inserted
into pDonr221 using a Gateway BP reaction to construct CycY-G2A-2pt-pDonr221,
which was sequence verified. CycY-G2A-2pt was transferred into pTWV-attB using the
Gateway LR reaction. The new plasmid was inserted into the P2 insertion site on
chromosome 3 by embryo injection (Genetic Services, Inc.)

3.2.2. Rescue experiments using the myristoylation defective transgenic flies.
To test the importance of the membrane localization through myristoylation on the
Cyclin Y functions, I set to rescue those phenotypes using the G2A shRNA resistant
CycY transgenic flies (YFP) and compare the results to those obtained from the shRNA
resistant CycY transgenic flies (YFP) used in Chapter 2. As in Chapter 2, fly strains with
the Gal4 lines and the G2A shRNA resistant CycY ORF were constructed (genotype:
xx-Gal4; CycY-G2A-2pt-YFP). These flies were crossed with the y1 sc* v1; +/+; UASshRNA attP2 flies for CycY or for mCherry as a control.
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3.2.3. Immunofluorescence and Immunohistochemistry:
3.2.3.1. Localization studies in S2R+ and S2 cells:
S2R+ and S2 cells were transfected according to the protocol described by
Dongmei Liu (Liu, 2010). Briefly, S2R+ cells and S2 cells were seeded in 6 well plates
(2 x 10 e6 cells /well and 2ml of Schneider media). The next day, the cells were
transfected with 10 µl of 50 ng/µl UAS-CycY-2pt or UAS- CycY-G2A-2pt and 10 µl of 50
ng/µl pMT-Gal4 using the Effectene transfection reagent (30 µl ) (Qiagen). The next day,
220 µl of 10mM CuSO4 was added to drive induction of the Cyclin Y-YFP in the cells.
The cells were harvested and plated on slide coverslips that were coated with
Concanavalin A (Sigma C5275). The coverslips were stained with 50 µl of DAPI (Sigma)
(1 µg/mL in PBX (PBS + 0.1% Triton-X 100) + 5% glycerol) then were placed on slides
with Vectashield mounting media. Images were taken with a Zeiss fluorescent
microscope.

3.2.5.2. Localization studies in vivo in Drosophila wing discs:
UAS-2pt-CycY or UAS-G2A-2pt-CycY flies were crossed with apterous-Gal4 flies
and grown in regular vials at 27°C. Wing discs from wandering third instar larvae were
dissected in phosphate buffered saline (PBS) (pH- 7.4, 10 mM PO43−, 137 mM NaCl,
and 2.7 mM KCl). The imaginal discs were fixed in PBS with 4% paraformaldehyde for
20 minutes at room temperature. Then the wing discs were blocked with 1ml of PBX
(PBS + 0.1% Triton-X 100) and 5% BSA for 1 hour at room temperature. Following that,
the wing discs were placed in wells with 50 µl of DAPI (Sigma - 1 µg/mL in PBX + 5%
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glycerol) for 20 minutes. Then they were washed with PBS and mounted on slides with
Vectashield mounting media. Images were taken with a Zeiss fluorescent microscope.

44

3.3. RESULTS

3.3.1. Cyclin Y is localized to the cell membrane in Drosophila through
myristoylation.
To determine the subcellular localization of Cyclin Y in Drosophila cells, I induced
the expression of wild type and myristoylation defective (G2A) Cyclin Y-YFP in S2R+
and S2 cells. S2 and S2R+ cells are derived from late embryos. S2R+ cells are
adherent cells (Schneider, 1972). S2 cells are semi adherent cells (Yanagawa et al.,
1998). The cells were transfected with pMT-Gal4 and pUASt-CycY-YFP or pUAStCycY-G2A YFP. As indicated in Figure 3-1, wild type Cyclin Y was localized to the cell
membrane in S2R+ cells (3-1.a.) as well as in S2 cells (3-1.b.), while the myristoylation
defective Cyclin Y G2A-YFP was localized to the cytoplasm and the nucleus (3-1. c. and
d.). Similar Cyclin Y localization results were obtained in vivo in Drosophila L3 larval
wing discs (Fig. 3-2) where apterous-Gal4 driven wild type Cyclin Y was localized to the
cell membrane while the Cyclin Y G2A-YFP was localized to the cytoplasm. These
results are consistent with the human Cyclin Y localization studies (Davidson et al.,
2009; Jiang et al., 2009).
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Figure 3-1. Cyclin Y localizes to the cell membrane in Drosophila cells through a
myristoylation signal sequence. YFP is membrane localized in Drosophila S2R+ (a.)
and S2 (b.) cells transfected with UAS-2pt-CycY and pMT-Gal4 and at the cytoplasm
and the nucleus in Drosophila S2R+ (c.) or S2 (d.) cells transfected with CycY-G2A-2ptCycY and pMT-Gal4 (Methods).
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Figure 3-2. Cyclin Y localizes to the cell membrane in vivo in Drosophila L3 wing
discs through a myristoylation signal sequence. YFP is membrane localized in
Drosophila third instar larval wing discs ubiquitously expressing CycY-2pt-YFP (apGal4/+; UAS-CycY-2pt-YFP/+) and at the cytoplasm and the nucleus in wing discs of
flies expressing a myristoylation defective Cyclin Y, CycY-G2A-2pt YFP (Genotype: apGal4/+; UAS-CycY-G2A-2pt-YFP/+).
3.3.2. The effect of membrane localization on the Cyclin Y functions.
In the tissue-wide screen discussed in Chapter 2, I found that expression of the
CycY shRNA in the engrailed or serrate expression patterns resulted in wing blister
formation in the posterior wing disc or the distal wing portion respectively.

This

phenotype is an indication of a cell adhesion defect (Brown, 1993; Brown, 2000; Brown
et al., 2000). To study the effect of the membrane localization of Cyclin Y on its cell
adhesion function, I attempted to rescue the wing blister phenotype using the
myristoylation defective Cyclin Y G2A-YFP and compared the rescue results to those of
the Cyclin Y-YFP shown in Chapter 2. The myristoylation defective Cyclin Y G2A-YFP
could suppress the CycY shRNA-induced wing blister phenotype. En-Gal4 expression
of the shRNA caused 64% (+/-2) of the posterior wing to be blistered, which was
reduced to 44.5% (+/- 2) by co-expression of Cyclin Y G2A-YFP (Figure 3-3). This is
significantly less than the UAS-GFP control with the Cyclin Y knockdown where 58.4%
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(+/- 2.4%) of the wing area was blistered (p=5.0e-5) (Figure 3-3). Also, the
myristoylation defective Cyclin Y G2A-YFP could suppress the wing blister phenotype
due to expression of the CycY shRNA in the serrate pattern. Ser-Gal4 expression of the
CycY shRNA resulted in 46% (+/- 2) of the adults having wing blisters, which was
reduced to 5% (+/- 4) by co-expression of Cyclin Y G2A-YFP (Figure 3-4). This is
significantly less than the UAS-GFP control with the Cyclin Y knockdown where 31%
(+/- 14%) of the flies showed blistered wings (p=0.04) (Figure 3-4). Put together these
results suggest that membrane localization is not essential for Cyclin Y to suppress the
wing blister phenotype induced by the CycY shRNA expression.

Figure 3-3. Membrane localization is not essential for Cyclin Y to suppress the
blister phenotype in the posterior wing. A myristoylation defective CycY transgene
(CycY-G2A-2pt-YFP) significantly reduces the wing blister produced by the Cyclin Y
shRNA in the posterior wing portion from 64%(+/-2) to 44.5% (+/- 2) defective area. This
is significantly less than the UAS-GFP control where 58.4% (+/- 2.4) of the wing area
was blistered (p=5.0E-05). All data other than the CycY-G2A-2pt-YFP is from Fig. 2-8.
The x-axis shows the % the posterior wing area that is blistered and the y-axis shows
the different genotypes tested in this experiment. Error bars = S.E.M.
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Figure 3-4. Membrane localization is not essential for Cyclin Y to suppress the
blister phenotype in the distal portion of the wing. The myristoylation defective
CycY transgene (CycY-G2A-2pt-YFP) reduces the number of flies with wing blisters
from 46% (+/-2) to 5% (+/- 4). This is significantly less than the UAS-GFP control where
31% (+/- 14) of the wing area was blistered (p=0.04). All data other than the CycY-G2A2pt-YFP is from Fig. 2-9. The x-axis shows the % of flies with dorsal wing blisters and
the y-axis shows the different genotypes tested in this experiment. Error bars = S.E.M.

The Cyclin Y-G2A transgene failed to rescue the bent leg phenotype induced by
the 48Y-Gal4 driven CycY knockdown. As indicated in Figure 3-5, while the Cyclin YYFP could suppress the bent leg phenotype caused by the CycY shRNA reducing the
flies with bent legs from 83% (+/-9) to 54%(+/-10), the Cyclin Y-G2A mutant was no
better than the UAS-GFP control at suppressing bent legs (p=0.24). This result
suggests that the membrane localization might be required for preventing the bent legs.
An alternate explanation is perhaps the 48Y-Gal4 induced Cyclin Y G2A expression
was not high enough to rescue the bent legs phenotype.
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Figure 3-5. Cyclin Y membrane localization may be essential for preventing the
bent leg formation. Unlike Cyclin Y (CycY-2pt-YFP), the myristoylation defective CycY
transgene (CycY-G2A-2pt-YFP) could not significantly reduce the number of flies with
bent legs in flies expressing the CycY shRNA (p=0.24). All data other than the CycYG2A-2pt-YFP is from Fig 2-4. The x-axis shows the % of flies with bent legs and the yaxis shows the different genotypes tested in this experiment. Error bars = S.E.M.
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3.4. DISCUSSION AND CONCLUSIONS:
In this Chapter, I studied Cyclin Y localization in Drosophila. I showed that Cyclin
Y is membrane localized when expressed in S2R+ cells, S2 cells and in vivo in
Drosophila wing discs. A G2A mutation in Cyclin Y, that disrupts the myristoylation
signal sequence (Maurer-Stroh et al., 2002; Wright Mh Fau - Heal et al.), resulted in
mislocalization of Cyclin Y to the cytoplasm and the nucleus. This indicates that in
Drosophila, the Cyclin Y membrane localization is due to the myristoylation signal
sequence.
I then investigated the effect of membrane localization through myristoylation on
the Cyclin Y functions. I showed that membrane localization was not required for the
putative roles for Cyclin Y in cell adhesion since the myristoylation defective, non
membrane localized, Cyclin Y G2A could partially suppress the wing blister phenotype
induced by CycY shRNA expression in the wing discs.
Previous studies have shown that human Cyclin Y is localized at the cell
membrane through an N-terminal myristoylation (Davidson et al., 2009; Jiang et al.,
2009). This myristoylation signal sequence is required for Cyclin Y to bind to LRP6 in
HEK293T cells and for maximal LRP6 phosphorylation at Sp1490 in combination with
Cdk14 (Davidson et al., 2009). Since the myristoylation defective Cyclin Y could rescue
the CycY shRNA induced wing blister phenotype, these results support the hypothesis
that Cyclin Y may have some functions outside the canonical Wg pathway in Drosophila
(Liu et al., 2010).
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CHAPTER 4

CYCLIN Y HAS FUNCTIONS OUTSIDE THE CANONICAL WINGLESS PATHWAY

4.1. INTRODUCTION
Studies in human and Drosophila cultured cells have suggested a possible role
for Cyclin Y in the canonical Wingless pathway (Davidson et al., 2009). Knockdown of
Cyclin Y and/or its Cdk partner, Eip63E (Cdk14), in cultured cells results in decreased
phosphorylation of the Wingless (Wg) or Wnt co-receptor, LRP6 (Arrow in Drosophila)
and decreased expression of Wg/Wnt reporter genes. Maximal LRP6/Arrow
phosphorylation and Wg/Wnt reporter activation also requires an N-terminal
myristoylation signal in Cyclin Y, which facilitates recruitment of Cdk14 to the cell
membrane (Jiang et al., 2009) where it can phosphorylate and activate Arrow/LRP6
(Davidson et al., 2009).
However, the CycY null does not phenocopy loss of function mutations in
members of the canonical Wg pathway, including arrow (Sharma and Chopra, 1976;
Wehrli et al., 2000; Willert et al., 1999); e.g., there is no wing loss or wing notching in
the adult CycY null escapers (Liu and Finley Jr, 2010). In addition, Cyclin Y with an Nterminal Myc tag, which disrupts the myristoylation sequence, is able to rescue the
lethality of the CycY null (Liu and Finley Jr, 2010), suggesting that membrane
localization is not required for at least some of the important functions of Cyclin Y in
vivo. These results led us to hypothesize that Cyclin Y is involved in molecular
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pathways outside of, or in addition to phosphorylation and activation of Arrow in the
canonical Wingless pathway in Drosophila (Liu et al., 2010).
Our results of the tissue wide CycY knockdown screen, shown in Chapter 2,
support this hypothesis. RNAi-mediated targeting of Cyclin Y in the en-Gal4 or ser-Gal4
expression patterns did not show wing notching, a phenotype that is expected for
mutants in canonical Wingless pathway genes and specifically for arrow mutants
(Sharma and Chopra, 1976; Wehrli et al., 2000; Willert et al., 1999). Also, a
myristoylation defective G2A Cyclin Y-YFP that is not membrane localized and,
therefore, would not be expected to efficiently activate Arrow (Davidson et al., 2009),
can suppress the CycY shRNA wing blister phenotype (Chapter 3). This suggests that
Cyclin Y has functions outside the canonical Wingless pathway since membrane
localization is not required for the role that Cyclin Y plays in preventing wing blisters. To
confirm that wing notching is the expected phenotype due to downregulation of the
canonical Wingless pathway and not wing blisters, in this chapter, I knocked down
arrow in the wing disc in the en-Gal4 or ser-Gal4 expression pattern.
Rather than a defect in wg signaling, the CycY shRNA-induced wing blister
phenotype indicates a failure of cell adhesion between the two epithelial layers of the
wing blade through their basal membrane. Normally, cells adhere to the extracellular
matrix (ECM) through focal adhesion complexes that bridge the ECM to the cell
cytoskeleton and defects in this process result in wing blisters (Brown, 1993; Brown,
2000; Brown et al., 2000). Focal adhesion is governed by the integrin pathway and its
cross talk with other pathways, including the Rho pathway (Huveneers and Danen,
2009). Overexpression of Paxillin, a focal adhesion docking protein, causes a wing
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blister that can be suppressed by overexpression of a downstream member of the Rho
pathway, LIMK1 [69]. LIMK1 has two known roles in focal adhesion. One role is to
promote Actin filament assembly by negatively regulating the disassembly factor Cofilin,
while the other role is to activate the Serum Response Factor (SRF) transcription factor,
which controls many genes required for focal adhesion (Chen et al., 2004; Ohashi et al.,
2000; Schratt et al., 2002). To link Cyclin Y to a molecular pathway in the wing disc, we
hypothesized that Cyclin Y is required in the focal adhesion process through the Integrin
pathway or Rho pathway. In this chapter I tested for a genetic interaction between
Cyclin Y and LIMK1 and found that LIMK1 overexpression could suppress the wing
blister phenotype induced by the CycY shRNA.

Another protein that has been shown to play a role in the Rho pathway is Cdk5.
Cdk5 is also a potential partner for Cyclin Y in C. elegans (Ou et al., 2010). In the Rho
pathway, Cdk5 is required for cell-matrix adhesion in rabbit lens epithelial cells
N/N1003A (Negash et al., 2002). It is also required for the activation of the Rho-ROCK
pathway in human lens epithelial cells (Tripathi and Zelenka, 2009) as well as for PAK1
phosphorylation in COS cells (Rashid et al., 2001). P35 is the known Cdk5 partner, yet
to the best of our knowledge, while Cdk5 is ubiquitously expressed in Drosophila, p35 is
either not expressed or expressed at low levels in the wing discs. (Chintapalli et al.,
2007; Graveley et al., 2011; Ou et al., 2010). Since p35 binds to Cdk5, overexpression
of p35 in the wing disc could result in sequestration of the Cdk5 making it unavailable
for a possible function with Cyclin Y in the Rho pathway. I tested for genetic interaction
between CycY and p35 in the Drosophila wing discs and found that p35 overexpression
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greatly enhanced the wing blister phenotype and significantly increased the number of
flies with wing blisters induced by the CycY shRNA. This suggests that the Cyclin Y’s
putative cell adhesion function in the wing disc could, be at least partly, through its
activation to Cdk5.
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4.2. MATERIALS AND METHODS
4.2.1 Fly stocks
For arrow knockdown, I used a dsRNA that targets arrow that was created by
the pTRiP project (Bloomington stock center # 31473, Finley stock # 983). For testing
LIMK1 genetic interactions, UAS-LIMK1 (Bloomington stock center # 9116, Finley fly
stock # 980) was crossed with the CycY shRNA to construct a fly strain UAS-LIMK1,
UAS-CycY-shRNA (Finley stock # 1097). This fly strain was crossed with ser-Gal4 and
the F1 wings were quantified. For testing the p35 genetic interaction, UAS-p35; TM3Ser/Sb (Finley fly stock # 447) was crossed with the CycY shRNA to construct a fly
strain UAS-p35, UAS-CycY-shRNA (Finley stock # 1096). This fly strain was crossed
with ser-Gal4 and the F1 wings were monitored and quantified. Both LIMK1 and p35
genetic interaction testing was run 5 independent times with different parental flies each
time.
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4.3. RESULTS
4.3.1. Expression of an arrow-targeting dsRNA in the engrailed or serrate patterns
does not phenocopy the CycY shRNA.
If Cyclin Y functions exclusively in the canonical Wingless pathway by
recruiting Cdk14 to the cell membrane where it phosphorylates the Wg co-receptor
Arrow, then we might expect similar phenotypic consequences from knocking down
arrow or CycY. To test this I expressed a dsRNA targeting arrow in the en-Gal4 and serGal4 expression patterns and compared the resulting phenotypes to those induced by
the CycY shRNA (see Chapter 2). Neither en-Gal4 driven nor ser-Gal4 driven
expression of the arrow dsRNA showed any wing blistering or wing crumpling as seen
in CycY knockdown (Fig. 4-1 a & b). Instead, targeting arrow in the en-Gal4 or ser-Gal4
patterns resulted in notched wings in 34% (+/-4) and 5% (+/-0) of the animals
respectively, a phenotype that is known for mutants of the canonical Wingless pathway
genes and specifically for arrow mutants (Sharma and Chopra, 1976; Wehrli et al.,
2000; Willert et al., 1999). The strikingly different phenotypes between the arrow dsRNA
and the CycY shRNA suggest that, in the wing discs, Cyclin Y has other functions
outside the canonical Wingless pathway.
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Figure 4-1 Expression of a dsRNA against arrow in the wing discs results in wing
notching and not wing blisters. Both engrailed or serrate driven expression of arrow
dsRNA results in wing notching in 34% (+/-4) (n=24, 32, 41) and 5%(+/-0) (n=63, 38)
respectively and no wing blisters in the Drosophila wing discs. Figures ai, aii, bi, and bii
are from Figures 2-8 and 2-9.
4.3.2. Overexpression of LIMK1, a cofilin kinase, results in supression of the CycY
shRNA induced wing blister phenotype.
The wing blister and absence of margin defects that occured upon expression
of the CycY shRNA in wing discs suggests that Cyclin Y functions in a pathway other
than the canonical Wingless pathway. The wing blister phenotype indicates a failure of
cell adhesion between the two epithelial layers of the wing blade through their basal
membrane. To test for a functional relationship between Cyclin Y and the Rho pathway,
I tested whether overexpression of LIMK1 could suppress the wing blister phenotype
induced by the CycY shRNA in the wing discs in the ser-Gal4 pattern. As shown in
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Figure 4-2, overexpression of LIMK1 completely supressed the CycY shRNA-induced
wing blister. Whereas ser-Gal4-driven expression of the CycY shRNA resulted in distal
wing blisters in 44% of the flies, none of the flies had wing blisters in the presence of a
UAS-LIMK1 transgene

(one tail t-test- p=2.9E-05) (Figure 4-2). This suggests that

Cyclin Y and LIMK1 have cooperative roles in the cell adhesion of the wing blades and
that Cyclin Y lies upstream from LIMK1.
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Figure 4-2 LIMK1 functionally interacts with Cyclin Y in the Drosophila wing
discs. Ser-Gal4 driven expression of the CycY shRNA resulted in distal wing blisters in
44% (+/-3) of the flies. Overexpression of LIMK1 resulted in complete supression of the
wing blisters (one tail t-test- p=2.9E-05). Ser-Gal4/+, UAS-CycY shRNA/+ and SerGal4/+, UAS-mCherry shRNA/+ are from Fig. 2-9. The x-axis shows the % of flies with
wing blisters and the y-axis shows the different genotypes tested in this experiment.
Error bars = S.E.M.

While the wing blister phenotype was completely supressed by the
overexpression of LIMK1, interestingly, the combination of CycY shRNA and LIMK1
overexpresssion resulted in the formation of ectopic wing veins with high penetrance
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(95%; +/- 5; Figure 4-2 A). Extra wing veins were not seen with CycY knockdown or
LIMK1 overexpresssion alone. This result suggests that Cyclin Y and LIMK1 have
antagonistic functions in wing vein formation in the wing intervein tissue.

4.3.3. P35 overexpression in the wing discs results in the wing blister phenotype
enhancement.
Another protein that has been shown to play a role in the Rho pathway is Cdk5 (Negash
et al., 2002; Rashid et al., 2001; Tripathi and Zelenka, 2009). Cdk5 is a potential cdk
partner for Cyclin Y in C. elegans (Ou et al., 2010). Even though Cdk5 is ubiquitously
expressed, P35 is either not expressed or expressed at low levels in the wing discs.
(Chintapalli et al., 2007; Graveley et al., 2011; Ou et al., 2010). Studies in the C.
elegans nervous system show that Cyclin Y and Cdk14 act in a parallell pathway with
P35 and Cdk5 (Ou et al., 2010). Ou and colleagues (Ou et al., 2010) suggest that Cdk5
could be another partner to Cyclin Y based on their finding that Cdk5 kinase activity
increases in the presence of CYY-1 in an in vitro kinase assay. To test for genetic
interactions between CycY and P35 in the wing discs, I crossed a UAS-P35 fly strain
with the CycY shRNA fly strain to obtain a new fly strain: UAS-P35; UAS CycY shRNA. I
used P35 overexpression (UAS-P35;TM3-Ser/Sb) & CycY knockdown (+/+,UAS-CycY
shRNA) as controls for the experiment. I crossed each of those strains with ser-Gal4. As
indcated in Figure 4-3, expression of P35 along with the CycY shRNA in the serrate
expression pattern resulted in a severe enhancement of the wing blister phenotype. The
CycY shRNA resulted in 44% (+/-3) of the flies with wing blisters in the distal side of the
wing (Fig. 2-9) while P35 expression resulted in 26% (+/-8) of the flies with wing blisters
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(Fig. 4-3). When p35 and the Cyclin Y shRNA were co-expressed, the wing blister
phenotype was seen in 97% (+/-2) of the flies (t-test p=1.5E-07). In addition, the wing
blister phenotype was more severe than the CycY shRNA alone (Fig. 4-3). These
results suggest that Cyclin Y and Cdk5 have cooperative roles in the cell adhesion of
the wing blades. Expression of p35 in the wing, where it is not normally expressed, may
result in sequestration of Cdk5 making it unavailable for its cell adhesion function.
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Figure 4-3: P35 functionally interacts with Cyclin Y in the Drosohila wing discs.
Ser-Gal4-driven expression of the CycY shRNA resulted in distal wing blisters in 44%
(+/-3) of the flies. Overexpression of p35 resulted in the phenotype enhancement where
97% (+/-2) of the flies had wing blisters (one tail t-test- p=1.5E-07) that were more
severe in appearance. Ser-Gal4/+, UAS-CycY shRNA/+ and Ser-Gal4/+, UAS-mCherry
shRNA/+ are from Fig. 2-9. The x-axis shows the % of flies with wing blisters and the yaxis shows the different genotypes tested in this experiment. Error bars = S.E.M.
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4.4. DISCUSSION AND CONCLUSIONS
Previous phenotypic analysis of CycY nulI flies and our tissue wide screen strongly
suggest that Cyclin Y has functions outside the canonical wingless pathway. In this
chapter I showed that the arrow dsRNA did not phenocopy the Cyclin Y loss of function
phenotypes in the Drosophila wings. Instead, it resulted in wing notching, a phenotype
that is expected for mutants in the canonical Wingless pathway genes and specifically
for arrow mutants (Sharma and Chopra, 1976; Wehrli et al., 2000; Willert et al., 1999).
This supports that Cyclin Y has functions outside of arrow activation in the canonical
Wingless pathway. In support of this, a myristoylation defective G2A Cyclin Y-YFP that
is not membrane localized and, therefore, would not be expected to efficiently activate
Arrow (Davidson et al., 2009), suppressed the CycY shRNA wing blister phenotype
(Chapter 3). Thus, membrane localization is not required for the role that Cyclin Y may
play in preventing wing blisters.
The wing blister phenotype suggests that Cyclin Y may be involved in cell
adhesion, which is governed by the integrin pathway and its cross talk with other
pathways. The Rho pathway is a main participant in this process (Huveneers and
Danen, 2009). Loss of function in members of the Rho pathway, such as the dSRF
transcription factor, results in wing phenotypes including wing blisters and defects in
wing vein and intervein patterns depending on the severity of the dSRF loss (Fristrom et
al.; Montagne et al.). Interestingly, even though I only saw extra wing veins with the
CycY shRNA was when co-expressed with LIMK1, wing vein defects were seen in other
CycY loss of function experiments (Liu, 2010) and (Figure 4-4). 69B-Gal4 driven CycY
knockdown in the wing disc using a dsRNA resulted in extra wing vein formation (Liu,
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2010). Consistently, the few CycY null escapers that flexed their wings showed clear
disruption of the wing vein–intervein pattern in the wing blades (Figure 4-4). The 69BGal4 expression of the CycY shRNA resulted in lethality by the larval stage, which
precluded parallel comparisons between the CycY shRNA and dsRNA in the wings. The
CycY dsRNA expressed with en-Gal4 or ser-Gal4 did not result in wing blisters. All the
Cyclin Y loss of function wing phenotypes are also seen in defects in the Rho pathway
(Fristrom et al.; Montagne et al.). The fact that all of those different wing phenotypes are
not seen together in each Cyclin Y loss of function experiment done in this study and in
previous ones (Liu, 2010) could be explained by the fact that those experiments target
different spatial and temporal regions of the wing disc. It could also be due to different
levels of severity of the Cyclin Y loss in the different experiments, or a combination of
both reasons.

Figure 4-4. Cyclin Y null escapers show wing crumpling, wing vein defects and no
wing notching. 3 out of 6 CycYE8 null escapers show flexed wings (Genotype: E8/E8;
+/+). All 3 of these flies have wing crumpling and unclear distinction between wing vein
and intervein tissue (i and ii). The wing crumpling is Cyclin Y specific because it is
rescued with a genomic Cyclin Y transgene where only 1 out of 69 flies show a wing
blister (Genotype: E8/E8; gCycY/+) (iii).

Consistent with a possible role for Cyclin Y in the Rho pathway or in
cooperation with the Rho pathway, I observed a strong genetic interaction between
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Cyclin Y and LIMK1, a downstream member of the Rho pathway (Chen et al., 2004).
Overexpression of LIMK1 suppressed the wing blister phenotype generated by the
CycY shRNA, suggesting that Cyclin Y and LIMK1 function cooperatively in positively
regulating cell adhesion between wing blades. Interestingly, the combination of CycY
shRNA and LIMK1 overexpression also resulted in extra wing veins with full penetrance
similar to the phenotype generated by 69B driven expression of a CycY dsRNA (Liu,
2010). En-Gal4 driven LIMK1 overexpression was also shown in another study to result
in extra wing vein formation (Chen et al., 2005). These results suggest that Cyclin Y and
LIMK1 act antagonistically in wing vein formation in the wing intervein tissue, at least in
the engrailed expression pattern, where Cyclin Y suppresses extra wing vein
development and LIMK1 enhances it.
Intriguingly, studies in human cells and C. elegans also point to a possible role
for Cyclin Y in the Rho pathway. A recent study in hepatocellular cancer cells (HKCI-3
and HKCI-C3), found that forced expression of Cyclin Y and Cdk14 resulted in an
increase of GTP-bound Rho pathway components, RhoA, Rac1 and Cdc42 and
increased stress fiber formation, a process regulated by the Rho pathway (Sun et al.,
2014). In C. elegans, Cdk16, a known Cyclin Y Cdk partner was shown to genetically
interact with and function epistatically to DHC-1 and NUD-2, two members of the Dynein
complex. Also in C. elegans, Cdk5 was shown as a putative Cyclin Y partner. The Rho
pathway has been connected to both the Dynein complex and Cdk5 functions in
previous studies. In wounded NIH 3T3 fibroblasts, Cdc42, Dynein and Dynactin were
required for mediating reorientation of the microtubule organizing center (MTOC), and
Cdc42 functioned epistatically to Dynein and Dynactin in this process (Palazzo et al.,
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2001). Cdk5 was shown to be required for cell-matrix adhesion in rabbit lens epithelial
cells (Negash et al., 2002), for activation of the Rho-ROCK pathway in human lens
epithelial cells (Tripathi and Zelenka, 2009), and for PAK1 phosphorylation in COS cells.
(Rashid et al., 2001). This is consistent with the results of a genetic interaction between
Cyclin Y and p35 where forced expression of p35 in the wing discs combined with the
knockdown of Cyclin Y, resulted in enhancement of the wing blister phenotype. This
could be due to sequestration of Cdk5 by the ectopically expressed P35 rendering it
unavailable for its function in cell adhesion. To the best of our knowledge, p35 is
normally either not expressed or expressed at low levels in the wing discs. (Chintapalli
et al., 2007; Graveley et al., 2011). The genetic interaction results between Cyclin Y and
p35 also suggests that Cyclin Y and Cdk5 have a cooperative function in the cell
adhesion process.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS

5.1. SUMMARY OF CONCLUSIONS:
In this study I aimed to discover biological functions of Cyclin Y using Drosophila
as a model organism. I started my study with a tissue-specific, tissue-wide knockdown
screen for lethality in the different Drosophila developmental stages as well as abnormal
phenotypes using a CycY shRNA and 31 Gal4 lines. The screen results suggested that
Cyclin Y might be required in several biological systems for development and survival
such as the nervous system and the gut. The screen results also supported our
hypothesis that Cyclin Y has functions outside of the Drosophila canonical wingless
pathway. Unlike arrow knockdown, there was no wing loss or wing notching upon
knockdown of Cyclin Y in the wing discs. Instead, a wing blister phenotype was seen,
which suggests a defect in cell adhesion between the wing blades. The wing blisters
were partially rescued by a CycY shRNA resistant transgene, which supported that it is
a Cyclin Y specific phenotype. Also in support to a function for Cyclin Y outside the
canonical

wingless

pathway,

expression

of

a

myristoylation

defective,

non-

membranous, CycY shRNA resistant transgene partially rescued the wing blister
phenotype. Finally, I showed that Cyclin Y genetically interacted with LIMK1 and p35;
both genes have functions in the Rho pathway, a major player in the cell adhesion
process.
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5.2. A Putative Model for the Cyclin Y Function in the Drosophila Wing Discs:
In this study, I showed that expression of a CycY shRNA, using en-Gal4 or serGal4, resulted in wing blister formation (Chapter 2). When LIMK1, a cofilin kinase and a
member of the Rho pathway, was co-expressed with the CycY shRNA in the ser-Gal4
expression pattern, the wing blister phenotype was supressed and extra wing veins
developed (Chapter 4). One LIMK1 function is to phosphorylate and activate the
transcrition factor dSRF (also known as Blistered) (Chen et al., 2004). Expression of a
CycY dsRNA in the wing discs does not cause blisters but can result in extra wing vein
formation in some tissue patterns (Liu, 2010), while CycY null escapers show a
complete distortion in the wing vein, intervein pattern (Chapter 4). Blistered mutants
show several phenotypes including wing blisters, extra wing vein formation and
complete transformation of the wing to vein tissue (Fristrom et al.; Montagne et al.).
These phenotypes are similar to the Cyclin Y mutant phenotypes and suggest, along
with the genetic interaction between Cyclin Y and LIMK1, that Cyclin Y functions either
in the Rho pathway or in a parallel pathway that has overlapping functions with the Rho
pathway. Consistently, a recent study in hepatocellular cancer cells (HKCI-3 and HKCIC3) suggests a role for Cyclin Y in the Rho pathway where forced expression of Cyclin
Y and Cdk14 resulted in an increased GTP-bound Rho pathway components, RhoA,
Rac1 and Cdc42 and increased stress fiber formation, a process regulated by the Rho
pathway (Sun et al., 2014).
Studies suggest that Cyclin Y physically and genetically interacts with Snr1, a
members of the BRM complex (Giot et al., 2003; Liu, 2010; Terriente-Felix and de Celis,
2009). Expression of an snr1 dsRNA in the Drosophila wing disc results in extra wing
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vein formation in the wing intervein region (Liu, 2010). CycY dsRNA expression in wing
disc also results in flies with the extra wing vein phenotype. The combined expression of
both CycY dsRNA and snr1 dsRNA in the wing disc results in the enhancement of the
extra wing vein phenotype (Liu, 2010). Snr1 activity is suggested to be regulated by
Cyclin Y through phosphorylation (Liu, 2010). The extra wing vein phenotype is also
observed in snr1 mutant flies, SNR1E1 (Marenda et al., 2004). This phenotype is
enhanced by the loss of function blistered mutant, bs2 . The strong extra wing vein
phenotype that is induced by the genetic interaction between the snr1 and the bs
mutants is partially supressed by the Brm mutant brm2 (Marenda et al., 2004). Brm
mutants show loss of wing veins (Liu, 2010; Marenda et al., 2004; Terriente-Felix and
de Celis, 2009). Bs-LacZ expression is reduced in the wing interveins of the snr1
mutant, snr1E1/snr1R3, pupal wings and is ectopically expressed in the L3 provein region
when the brmK804R transgene is overexpressed (Marenda et al., 2004). These results
suggest that Snr1 and Brm positively and negatively regulate blistered expression in the
wing discs, respectively. (Marenda et al., 2004). They also provide some explanation to
the extra wing vein phenotype observed with the Snr1 loss of function and the loss of
wing veins observed with the Brm loss of function (Liu, 2010; Marenda et al., 2004). If
Cyclin Y funtions in positive regulation of Snr1 in the wing discs, then loss of Cyclin Y
function would result in downregulation of Snr1 and thus underexpression of Blistered.
The similarity in the Cyclin Y and Blistered loss of function phenotypes such as the extra
wing veins, the blistered wings and the disrupted wing vein structure strongly support
this model (Chapter 2 & 4) and (Fristrom et al.; Liu, 2010; Montagne et al.) This is also
supported by the suppression of the CycY shRNA wing blister phenotype upon
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overexpression of LIMK1 (Chapter 4), an upstream regulator of blistered (Chen et al.,
2004) which also suggests that Cyclin Y and Snr1 are upstream of both LIMK1 and
Blistered. When LIMK1 supressed the CycY shRNA wing blister, the extra wing vein
phenotype was enhanced (Chapter 4). This could be explained by the fact that Snr1
regulates several other contributors to the wing vein development other than Blistered
such as delta, rhomboid and argos (Marenda et al., 2004; Terriente-Felix and de Celis,
2009). It could also suggest that the wing blister phenotype is dominant to the extra
wing vein phenotype.
Cyclin Y has two potential Cdk partners, Cdk14 and Cdk5. Both are expressed
in Drosophila wings (Chintapalli et al., 2007; Graveley et al., 2011) and potentially have
redundant functions (Liu and Finley Jr, 2010; Ou et al., 2010; Stanyon et al., 2004). Put
together, I propose the following model (Figure 5-1). In the Drosophila wing discs,
Cyclin Y along with Cdk14 or Cdk5 or both, binds to and activates Snr1 which in turn
regulates many downstream targets. One result is positive regulation of Blistered
(dSRF) expression resulting in the regulation of both wing cell adhesion and wing vein
development.
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Figure 5-1: A Putative Cyclin Y Functional Model in the Drosophila wing discs.
Cyclin Y is upstream of members of the Rho pathway such as LIMK1 and SRF and
might regulate the Rho pathway through activation of Snr1, a member of the BRM
complex.
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5.3. FUTURE DIRECTIONS:
This study laid the foundation to many other possible future Cyclin Y functional
studies. Several hypotheses about the functions of Cyclin Y in the wing discs as well as
in other biological systems could be proposed and tested based on the results of this
study and the proposed model.
Starting with the wing disc, I hypothesize that Cyclin Y mutants could affect
SRF expression, regulation and hence its activity in regulating its target genes. This
could be tested with measuring the expression level of dSRF in the wing discs upon
alteration of the Cyclin Y expression level through knockdown or overexpression. Also
SRF-responsive promoters such as SRE Luciferase could be used to measure the SRF
transcrpition activity.
In addition to its function in dSRF activation, LIMK1 promotes actin filament
assembly by negatively regulating the actin disassembly factor, cofilin (Chen et al.,
2004; Ohashi et al., 2000; Schratt et al., 2002). I hypothesize that Cyclin Y functions in
F-actin stabilization and functions. Drosophila wing discs represent a good model
system to study F-actin stabilization (Chen et al., 2005).
Countless other questions could be asked about the function of Cyclin Y in the
wing discs. Here I propose a few more. In early stages of the Drosophila wing disc
development, dSRF is expressed in the whole wing and then gradually lost from the
vein tissue and restricted to the intervein tissue, where it functions cell autonomously
(Fristrom et al.; Roch et al., 1998). What is the Cyclin Y expression pattern during
different stages of the wing discs development and does it follow the dSRF expression
pattern? Does Cyclin Y function cell autonomously?
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The Cyclin Y functional analysis could also be extended to other biological
systems besides the wing discs in Drosophila. In the CycY knockdown screen described
in chapter 2, I screened for lethality in each developmental stage in specific tissue
patterns as well as for abnormal phenotypes in adult flies. 13 out of the 31 Gal4 lines
showed lethality (Table 2-1). Each of the 14 tissue patterns could be used as a model to
study other tissue specific Cyclin Y functions. But are all of the lethality results obtained
from the screen due to specific CycY knockdown? To test that the lethality in each of
the 13 Gal4 expression patterns is due to specific CycY knockdown, an shRNA resistant
Cyclin Y could be expressed in each case. If the lethality is rescued by the shRNA
resistant Cyclin Y, then we could conclude that Cyclin Y is specifically knocked down in
those tissue patterns and that the lethality is Cyclin Y specific. The level of CycY could
also be measured in each Gal4 tissue pattern upon knockdown with the CycY shRNA
through in-situ hybridization and imaging of the dissected tissues of interest or through
monitoring the fluorescent expression level of a fluorescently tagged Cyclin Y inserted in
the tested flies.
Drosophila cultured cells could also be used to investigate hypotheses on
some putative Cyclin Y functions. The Rho pathway controls the formation of cell
protrusions such as fillopodia, lamellipodia and stress fibers (Nobes and Hall, 1999).
Rho controls stress fiber and focal adhesion formation. Rac controls lamellipodia
formation and Cdc42 controls fillopodia formation (Nobes and Hall, 1999). I hypothesize
that Cyclin Y affects the formation or stability of cell protrusions. Cell protrusions could
be studied in Drosophila cells such as S2 and S2R+ cells (Jani and Schock, 2007;
Varughese, 2011)
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And finally, the results in this study as well as previous Cyclin Y studies
strongly suggest that Cyclin Y has functions outside the wingless pathway (Liu, 2010;
Liu and Finley Jr, 2010). Another way to confirm that Cyclin Y functions outside the
wingless pathway in the wing discs is by measuring the expression of a marker for the
canonical Wingless pathway, e.g. senseless in the wing discs and compare it to
canonical Wingless mutants such as arrow mutants as well as wild type larvae (Schertel
et al.). Yet Cyclin Y could have functions in the canonical Wingless pathway in other
Drosophila tissue patterns. A function for Cyclin Y in the canonical Wingless pathway
could also be studied in the larval epidermis during the denticle belt formation process.
Loss of function of the canonical Wingless pathway positive regulators results in an
increase in the denticle area compared to wild type larvae (Swarup and Verheyen,
2012; Wehrli et al., 2000).
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Appendix A: Gal4 lines used in the tissue-wide screen in Chapter 2 and their
expression patterns.

Genotypes

Gal4 Expression
pattern
(Bloomington or
other annotation)

UAS-GFP expression
in 3rd instar larvae

Gal4
Driver

BDSC #
or other
source

GFP
in all
larvae

3039

pnr[+] patternDenticle belts,
salivary glands,
and imaginal discs
(Calleja	
  et	
  al.,	
  1996;
Giagtzoglou	
  et	
  al.,	
  
2005)

Yes

Pnr

y[1] w[1118];
P{w[+mW.hs
]= GawB}
pnr[MD237]/
TM3, P{w
[+mC]=UASy.C}MC2,
Ser[1]

Yes	
  

Denticle belts; salivary
glands; imaginal discs

6356

Epidermis in engrailed
pattern; imaginal discs;
clearly in posterior half
of wing disc; some
parts of the gut. Not
seen in salivary
glands. Very slightly
expressed in the
proventirculus. Not in
the optical lobes

Yes	
  

Sca

En

y[1] w[*];
P{w[+mW.hs
] =en2.4GAL4}e16E
P{w[+mC]=U
AS-FLP1.
D}JD1

en[+] pattern- The
gut, the posterior
wing discs and
some parts of the
nervous system
(Gettings	
  et	
  al.,	
  
2010; Harrison	
  et	
  
al.,	
  1995; Johnson	
  
et	
  al.,	
  1995)

Very weak expression in
optical lobes and other
scattered parts of the
larval head around the
mouth

6479

y[1] w[*];
P{w[+mW.hs]
= GawB}
sca[109-68]

A subset of the wild
type sca
expression pattern:
Some pan-neural
clusters and
sensory organs
precursor cells

Images
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Genotypes

GFP in
all
larvae

Gal4
Driver

UAS-GFP
expression in
3rd instar
larvae

Yes

BDSC #
or other
source
Weak in
imaginal discs
and brain.
Strong in
salivary glands.

Yes	
  

Act5C *

Gal4 Expression
pattern
(Bloomington or
other annotation)

Ubiquitous

Yes

6980

y[1] w[*];
Ubiquitous
P{w[+mC]=Act5CGAL4}25FO1/CyO
,P{w[+mC]=ActGF
P}JMR1

Muscles

C253

4414

w-; MHC-Gal4 ry+ Weak muscle
(3rd chromosome) driver

w[1118];
P{w[+mW.hs]=
GawB}C253

(Perrimon
lab)

Embryonic
epidermal cells
and larval brain
and wing disc

MHC

6791

Yes	
  

Ser

w[*]; P{w[+mC]=
Ser-GAL4.GF}1
P{Ser-GAL4.GF}2

Along future wing
margin in dorsal
compartment of
wing imaginal
discs-The nervous
system and
imaginal discs
(Fleming	
  et	
  al.,	
  1997;
Hukriede	
  et	
  al.,	
  1997)

Images
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Gal4
Driver

Ptc

Cg

69B

BDSC #
or other
source
(Perrimon
lab)

7011

1774

w[1118];
P{w[+mC]=C
g-GAL4.A}2

ptc-Gal4
(Ch2)

Genotypes

Hemocytes, fat
body and lymph
glands (Hennig et
al., 2006)

ptc[+] pattern- The
nervous system,
the gut, salivary
glands and
imaginal discs
(Brand, 1997;
Gettings et al.,
2010; Monastirioti,
2003; Page, 2002)

Gal4 Expression
pattern
(Bloomington or
other annotation)

Hemocytes; fat
body; lymph
glands

Nerves; imaginal
discs; salivary
glands; parts of
the gut

UAS-GFP
expression in
3rd instar
larvae

Yes

Yes

Yes

GFP in
all
larvae

w[*];
Ubiquitous in
P{w[+mW.hs] epidermis
=GawB} 69B

Images

	
  

Nervous system;
gut; salivary
glands; imaginal
discs; epidermis
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Gal4
Driver

Vg *

24B

4G

BDSC #
or other
source

Genotypes

GFP in
all
larvae

Gal4 Expression
pattern
(Bloomington or
other annotation)
Yes

UAS-GFP
expression in
3rd instar
larvae

Vestigial gene in
the wing disc

Salivary gland
and imaginal
discs

6819

vgGal4/CyO,
P{w[+mC]=
ActGFP}JM
R1; TM3
Ser/Sb

Yes

1767

Muscles; gut
muscles;
salivary glands

Yes

w[*];
P{w[+mW.hs
]=GawB}
how[24B]

Embryonic
mesodermMesoderm, larval
muscles, nervous
system, and
trachea
(Osterwalder	
  et	
  al.,	
  
2004; Staehling-‐
Hampton	
  et	
  al.,	
  
1994; Suster	
  et	
  al.,	
  
2003)

Nervous system;
salivary glands

6927

w[*] ;
Pan-neural in late
P{w[+mW.hs] embryos, in a
=GawB} 4G	
   subset of motor
neurons in 3rd
instar larvae, and
enriched in
mushroom bodies
in adults

Images
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Gal4
Driver

D42

48Y

OK376

Genotypes

Expresses GFPtagged, wild type nsyb protein in 3rd
instar motor
neurons (Yeh	
  et	
  al.,	
  
1995)

Gal4 Expression
pattern
(Bloomington or
other annotation)
Brain; salivary
glands

UAS-GFP
expression in
3rd instar larvae

Yes

Yes

GFP in
all
larvae

9263

w[*];
P{w[+mW.hs]
=GawB} D42,
P{w[+mC]=U
AS-nSybGFP.E}3/TM3
, Sb[1]

Stripped pattern
in epidermis;
nervous system;
salivary gland;
parts of the
midgut

BDSC #
or other
source

4935

w[*];
P{w[+mW.hs]
=GawB} 48Y

Endoderm- The
nervous system,
the gut and parts of
the epidermis
(Martin-‐Bermudo	
  et	
  
al.,	
  1997; Riese	
  et	
  al.,	
  
1997; Szuts	
  et	
  al.,	
  
1998)

.hs]=
GawB}OK376

w[*]; P{w[+mW Oenocytes

Yes

6487

GFP over the
length of the
larvae in fat like
cells in the gut
(oenocytes);
strong in foregut
and imaginal rings

Images
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Gal4
Driver

Dpp *

112A

Mef2

BDSC #
or other
source
7006

7021

27390

Genotypes

Yes

[+mC]= dpp
GAL4.PS}l
(3)8B[8B]
P{w[+mC]=dp
p-GAL4.

GFP in
all
larvae

Gal4 Expression
pattern
(Bloomington or
other annotation)
Patches on
epidermis;
salivary gland

Yes

P{w[+mW.hs]
PS}
6A/
=GawB}112A
Act
,TM3Ser,
w[*]	
  
GFP

UAS-GFP
expression in
3rd instar
larvae

y[1] w[67

Spiracular branch
10 and posterior
spiracle beginning
at stage 12,
continuing through
stage 17, and
cells of the dorsal
ectoderm

Very strong
expression in
many parts of
the gut and
surrounding
cells as well as
in optical lobes.
Not seen in
muscles,
epidermis or the
salivary glands.

Yes

c23]; P{w

Embryonic
epidermis, stalk
cells, follicle cells
at the anterior and
posterior poles of
the egg chamber.
(Crowner	
  et	
  al.,	
  
2002; Larkin	
  et	
  al.,	
  
1996; Younger,	
  
2001)

Muscles

y[1] w[*];
Muscle cells
P{w[+mC]=GA
L4-Mef2.R}3

Images
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Gal4
Driver

Feb36

Hml

Aug21 *

BDSC
# or
other
source
29968

30140

30137

Genotypes

w[*]; P{w
[+mW.hs]=
GawB}Feb36

w[1118]; P{w
[+mC]=HmlGAL4.Delta}2
, P{w[+mC]=
UAS2xEGFP}AH2
w[*]; P{w
[+mW.hs]=
GawB}Aug21/
CyO, P{w
[+mC]=ActGF
P}JMR1	
  

Corpora allata in
the larval ring
gland and Tv
neurons in the
thoracic ganglion
(Thummel,	
  2010)

Lymph glands and
circulating
hemocytes

Strongly in the
larval prothoracic
gland and corpora
allata and weakly
in tracheae,
Malpighian
tubules and some
midgut cells.

Gal4 Expression
pattern
(Bloomington or
other annotation)

Nervous system

Circulating cells
and two oval
structures at
very top of the
mouth

The optical
lobes and along
the gut

UAS-GFP
expression in
3rd instar
larvae

Yes

Yes

Yes

GFP in
all
larvae

Images
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Gal4
Driver

c578

BDSC #
or other
source

Genotypes

Embryonic and
larval midgut and
salivary gland

Gal4 Expression
pattern
(Bloomington or
other annotation)
Gut and
epidermis. Not
seen in salivary
gland

UAS-GFP
expression in
3rd instar
larvae

Yes

Yes

GFP in
all
larvae

33832

w; gmr-Gal4;
TM3-sb/Xa

y[1] w[*];
P{w[+mC]=r
4-GAL4}3

32548

w[*]; CyO,
P{w[+mW.hs
]= GawB}

Fat body;
salivary glands
and all along the
epidermis

Yes

GMR

Todi, S.
lab

c578
Fat body and
salivary glands

(In pupae)
clearly in eyes

Yes

4918

r4

Photoreceptor
cells

Imaginal discs;
ring around the
foregut imaginal
ring; patches on
epidermis; small
patch in gut.

Salivary gland

Salivary glands
(Note: only seen
in older L3 larvae
and pupae)

Yes - In
older L3
larvae
and
pupae.

wg[+] pattern in
embryos, no
expression in
discs (per
FlyBase)

Wg

6870

w[*];
P{GAL4wg.M}MA1

Sgs3

w[1118];
P{w[+mC]=S
gs3-GAL4.
PD}TP1	
  

	
  

Images

	
  

	
  

	
  

	
  

	
  

83

Gal4
Driver

Eip71CD

c601

Elav *

Repo *

Genotypes

GFP in
all
larvae

UAS-GFP
expression in
3rd instar
larvae
Yes
(older)

Gal4 Expression
pattern
(Bloomington or
other annotation)

BDSC #
or other
source

Yes

Larval epidermis
and brain cells

Salivary gland;
midget; hindgut;
beginning of
malphigian
tubules; not
seen in
proventriculus

Yes

6871

Hindgut, ureter,
Malpighian
tubules &
protocerebrum
(Johnson	
  et	
  al.,	
  
1995)

Nervous system

Larval
epidermis; brain
cells; gut.

Pan-neural- (Lin	
  
and	
  Goodman,	
  
1994; Zhan	
  et	
  al.,	
  
2004)

Yes

w[1118];
P{w[+mC]=
Eip71CDGAL4.PC}T
P1-1

Glia

w[*]; P{w
[+mW.hs]=
GawB} c601
[c601]

Elav-Gal4/
CyO, P{w
[+mC]= Act
GFP}JMR1
w1118; repoGAL4/
TM3Ser, Act
GFP	
  

Nervous system;
salivary glands

30844

Vanberkum, M.
lab

7415

* Homozygous lethal

	
  

Images
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Appendix B. Sequences of primers used in the study described in Chapter 2.
Primers
Primers
Sequences
Finley lab Alias
#
1224
NG11
5'GGGGACAAGTTTGTACAAAAAAGCAGGCTCCGGCAA
AATGGGCAACAAG
1225

NG12

5’GGGGACCACTTTGTACAAGAAAGCTGGGTCCGATA
GTATGGCCACGCTG

1227

NG15

5’GCGATCATAACCCTAGTCTACC

1228

NG16

5’GGTAGACTAGGGTTATGATCGC

1231

NG21

5’GAGAACTCTGAATAGGCAATTGGGAAT

1232

NG22

5’CCTTCACAAAGATCCTCTAGCTTACGT

1233

NG23

5’AAGAAGAGAACTCTGAATAGGGAATTG

1234

NG24

5’CTGGTGAAATGCAGTTTAAGGTTTAC

1235

NG25

5’ATAACGGCTCTCTCTTTTATAGGTGTA
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Appendix C. Plasmids used or constructed in the study described in Chapter
2.
Plasmids
Finely lab #

Plasmids Alias

Source or References

2129

ptWV-attB

This study

2130

ptWH-attB

This study

1032

pUASt-attB

(Bischof et al., 2007)

989

pDonr221

(Invitrogen)

966

pMT-Gal4

(Klueg et al., 2002)

2121

CycY-pDonr221

This study

2117

CycY no stop-pDonr221

This study

2118

CycY-2pt-no stop-pDonr221

This study

2127

pUASt-CycY-Venus-attB

This study

2123

pUASt-CycY-2pt-YFP-attB

This study

2125

pUASt-CycY-HA-attB

This study

2122

pUASt-CycY-2pt-HA-attB

This study
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Appendix D: pUASt-GW-3xHA attB (pTWH-attB) anticipated sequence.
pUASt-GW-3xHA-attB:
UASt promoter: 4861 … 5225
Gateway cassette: 5470 … 7173
attR1: 5470 … 5487
attR2: 7156 … 7173
3xHA: 7186 … 7321

CTGAAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATC
AGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGA
ATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTA
AAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGC
CCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAG
CACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGC
CGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAG
GGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGC
TTAATGCGCCGCTACAGGGCGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGG
GAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGG
ATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACG
TTGTAAAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTGGGT
ACGTACCGGGCCCCTAGTATGTATGTAAGTTAATAAAACCCATTTTTGCGGAAAG
TAGATAAAAAAAACATTTTTTTTTTTTACTGCACTGGATATCATTGAACTTATCTGA
TCAGTTTTAAATTTACTTCGATCCAAGGGTATTTGATGTACCAGGTTCTTTCGATT
ACCTCTCACTCAAAATGACATTCCACTCAAAGTCAGCGCTGTTTGCCTCCTTCTCT
GTCCACAGAAATATCGCCGTCTCTTTCGCCGCTGCGTCCGCTATCTCTTTCGCCA
CCGTTTGTAGCGTTACGTAGCGTCAATGTCCGCCTTCAGTTGCATTTTGTCAGCG
GTTTCGTGACGAAGCTCCAAGCGGTTTACGCCATCAATTAAACACAAAGTGCTGT
GCCAAAACTCCTCTCGCTTCTTATTTTTGTTTGTTTTTTGAGTGATTGGGGTGGTG
ATTGGTTTTGGGTGGGTAAGCAGGGGAAAGTGTGAAAAATCCCGGCAATGGGCC
AAGAGGATCAGGAGCTATTAATTCGCGGAGGCAGCAAACACCCATCTGCCGAGC
ATCTGAACAATGTGAGTAGTACATGTGCATACATCTTAAGTTCACTTGATCTATAG
GAACTGCGATTGCAACATCAAATTGTCTGCGGCGTGAGAACTGCGACCCACAAA
AATCCCAAACCGCAATTGCACAAACAAATAGTGACACGAAACAGATTATTCTGGT
AGCTGTTCTCGCTATATAAGACAATTTTTGAGATCATATCATGATCAAGACATCTA
AAGGCATTCATTTTCGACTATATTCTTTTTTACAAAAAATATAACAACCAGATATTT
TAAGCTGATCCTAGATGCACAAAAAATAAATAAAAGTATAAACCTACTTCGTAGGA
TACTTCGGGGTACTTTTTGTTCGGGGTTAGATGAGCATAACGCTTGTAGTTGATA
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TTTGAGATCCCCTATCATTGCAGGGTGACAGCGGAGCGGCTTCGCAGAGCTGCA
TTAACCAGGGCTTCGGGCAGGCCAAAAACTACGGCACGCTCCGGCCACCCAGT
CCGCCGGAGGACTCCGGTTCAGGGAGCGGCCAACTAGCCGAGAACCTCACCTA
TGCCTGGCACAATATGGACATCTTTGGGGCGGTCAATCAGCCGGGCTCCGGATG
GCGGCAGCTGGTCAACCGGACACGCGGACTATTCTGCAACGAGCGACACATAC
CGGCGCCCAGGAAACATTTGCTCAAGAACGGTGAGTTTCTATTCGCAGTCGGCT
GATCTGTGTGAAATCTTAATAAAGGGTCCAATTACCAATTTGAAACTCAGTTTGCG
GCGTGGCCTATCCGGGCGAACTTTTGGCCGTGATGGGCAGTTCCGGTGCCGGA
AAGACGACCCTGCTGAATGCCCTTGCCTTTCGATCGCCGCAGGGCATCCAAGTA
TCGCCATCCGGGATGCGACTGCTCAATGGCCAACCTGTGGACGCCAAGGAGAT
GCAGGCCAGGTGCGCCTATGTCCAGCAGGATGACCTCTTTATCGGCTCCCTAAC
GGCCAGGGAACACCTGATTTTCCAGGCCATGGTGCGGATGCCACGACATCTGAC
CTATCGGCAGCGAGTGGCCCGCGTGGATCAGGTGATCCAGGAGCTTTCGCTCA
GCAAATGTCAGCACACGATCATCGGTGTGCCCGGCAGGGTGAAAGGTCTGTCCG
GCGGAGAAAGGAAGCGTCTGGCATTCGCCTCCGAGGCACTAACCGATCCGCCG
CTTCTGATCTGCGATGAGCCCACCTCCGGACTGGACTCATTTACCGCCCACAGC
GTCGTCCAGGTGCTGAAGAAGCTGTCGCAGAAGGGCAAGACCGTCATCCTGACC
ATTCATCAGCCGTCTTCCGAGCTGTTTGAGCTCTTTGACAAGATCCTTCTGATGG
CCGAGGGCAGGGTAGCTTTCTTGGGCACTCCCAGCGAAGCCGTCGACTTCTTTT
CCTAGTGAGTTCGATGTGTTTATTAAGGGTATCTAGCATTACATTACATCTCAACT
CCTATCCAGCGTGGGTGCCCAGTGTCCTACCAACTACAATCCGGCGGACTTTTA
CGTACAGGTGTTGGCCGTTGTGCCCGGACGGGAGATCGAGTCCCGTGATCGGA
TCGCCAAGATATGCGACAATTTTGCTATTAGCAAAGTAGCCCGGGATATGGAGCA
GTTGTTGGCCACCAAAAATTTGGAGAAGCCACTGGAGCAGCCGGAGAATGGGTA
CACCTACAAGGCCACCTGGTTCATGCAGTTCCGGGCGGTCCTGTGGCGATCCTG
GCTGTCGGTGCTCAAGGAACCACTCCTCGTAAAAGTGCGACTTATTCAGACAAC
GGTGAGTGGTTCCAGTGGAAACAAATGATATAACGCTTACAATTCTTGGAAACAA
ATTCGCTAGATTTTAGTTAGAATTGCCTGATTCCACACCCTTCTTAGTTTTTTTCAA
TGAGATGTATAGTTTATAGTTTTGCAGAAAATAAATAAATTTCATTTAACTCGCGAA
CATGTTGAAGATATGAATATTAATGAGATGCGAGTAACATTTTAATTTGCAGATGG
TTGCCATCTTGATTGGCCTCATCTTTTTGGGCCAACAACTCACGCAAGTGGGCGT
GATGAATATCAACGGAGCCATCTTCCTCTTCCTGACCAACATGACCTTTCAAAAC
GTCTTTGCCACGATAAATGTAAGTCTTGTTTAGAATACATTTGCATATTAATAATTT
ACTAACTTTCTAATGAATCGATTCGATTTAGGTGTTCACCTCAGAGCTGCCAGTTT
TTATGAGGGAGGCCCGAAGTCGACTTTATCGCTGTGACACATACTTTCTGGGCAA
AACGATTGCCGAATTACCGCTTTTTCTCACAGTGCCACTGGTCTTCACGGCGATT
GCCTATCCGATGATCGGACTGCGGGCCGGAGTGCTGCACTTCTTCAACTGCCTG
GCGCTGGTCACTCTGGTGGCCAATGTGTCAACGTCCTTCGGATATCTAATATCCT
GCGCCAGCTCCTCGACCTCGATGGCGCTGTCTGTGGGTCCGCCGGTTATCATAC
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CATTCCTGCTCTTTGGCGGCTTCTTCTTGAACTCGGGCTCGGTGCCAGTATACCT
CAAATGGTTGTCGTACCTCTCATGGTTCCGTTACGCCAACGAGGGTCTGCTGATT
AACCAATGGGCGGACGTGGAGCCGGGCGAAATTAGCTGCACATCGTCGAACAC
CACGTGCCCCAGTTCGGGCAAGGTCATCCTGGAGACGCTTAACTTCTCCGCCGC
CGATCTGCCGCTGGACTACGTGGGTCTGGCCATTCTCATCGTGAGCTTCCGGGT
GCTCGCATATCTGGCTCTAAGACTTCGGGCCCGACGCAAGGAGTAGCCGACATA
TATCCGAAATAACTGCTTGTTTTTTTTTTTTACCATTATTACCATCGTGTTTACTGTT
TATTGCCCCCTCAAAAAGCTAATGTAATTATATTTGTGCCAATAAAAACAAGATAT
GACCTATAGAATACAAGTATTTCCCCTTCGAACATCCCCACAAGTAGACTTTGGAT
TTGTCTTCTAACCAAAAGACTTACACACCTGCATACCTTACATCAAAAACTCGTTT
ATCGCTACATAAAACACCGGGATATATTTTTTATATACATACTTTTCAAATCGCGC
GCCCTCTTCATAATTCACCTCCACCACACCACGTTTCGTAGTTGCTCTTTCGCTGT
CTCCCACCCGCTCTCCGCAACACATTCACCTTTTGTTCGACGACCTTGGAGCGAC
TGTCGTTAGTTCCGCGCGATTCGGTTCGCTCAAATGGTTCCGAGTGGTTCATTTC
GTCTCAATAGAAATTAGTAATAAATATTTGTATGTACAATTTATTTGCTCCAATATA
TTTGTATATATTTCCCTCACAGCTATATTTATTCTAATTTAATATTATGACTTTTTAA
GGTAATTTTTTGTGACCTGTTCGGAGTGATTAGCGTTACAATTTGAACTGAAAGTG
ACATCCAGTGTTTGTTCCTTGTGTAGATGCATCTCAAAAAAATGGTGGGCATAATA
GTGTTGTTTATATATATCAAAAATAACAACTATAATAATAAGAATACATTTAATTTAG
AAAATGCTTGGATTTCACTGGAACTAGGCTAGCATAACTTCGTATAATGTATGCTA
TACGAAGTTATGCTAGCGGATCCAAGCTTGCATGCCTGCAGGTCGGAGTACTGT
CCTCCGAGCGGAGTACTGTCCTCCGAGCGGAGTACTGTCCTCCGAGCGGAGTA
CTGTCCTCCGAGCGGAGTACTGTCCTCCGAGCGGAGACTCTAGCGAGCGCCGG
AGTATAAATAGAGGCGCTTCGTCTACGGAGCGACAATTCAATTCAAACAAGCAAA
GTGAACACGTCGCTAAGCGAAAGCTAAGCAAATAAACAAGCGCAGCTGAACAAG
CTAAACAATCTGCAGTAAAGTGCAAGTTAAAGTGAATCAATTAAAAGTAACCAGCA
ACCAAGTAAATCAACTGCAACTACTGAAATCTGCCAAGAAGTAATTATTGAATACA
AGAAGAGAACTCTGAATAGGGAATTGGGAATTGCAAAATGCACCATCACCACCAT
CACGGATTCGAGCTATGCGGCCGCTCTGAGCAAAAGCTCATTTCTGAAGAGGAC
TTGAATGGAGAACAGAAATTGATCAGTGAGGAAGACCTCAACGGTGAGCAGAAG
TTAATATCCGAGGAGGATCTTAATAGTAGCGGCCGCACTAGTCTCGAAGGGGGG
CCCCATATGTTGACTGTATCGCCGGAATTGGGAATTATCGACAAGTTTGTACAAA
AAAGCTGAACGAGAAACGTAAAATGATATAAATATCAATATATTAAATTAGATTTTG
CATAAAAAACAGACTACATAATACTGTAAAACACAACATATCCAGTCACTATGGCG
GCCGCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATAATGTGT
GGATTTTGAGTTAGGATCCGTCGAGATTTTCAGGAGCTAAGGAAGCTAAAATGGA
GAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAA
CATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCT
GGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGG
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CCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGC
AATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTT
TTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATT
TCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCT
GGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCT
GGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGC
CCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCC
GCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAAT
GCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGCGGGGCGTAATCTAGA
GGATCCGGCTTACTAAAAGCCAGATAACAGTATGCGTATTTGCGCGCTGATTTTT
GCGGTATAAGAATATATACTGATATGTATACCCGAAGTATGTCAAAAAGAGGTAT
GCTATGAAGCAGCGTATTACAGTGACAGTTGACACCGACAGCTATCAGTTGCTCA
AGGCATATATGATGTCAATATCTCCGGTCTGGTAAGCACAACCATGCAGAATGAA
GCCCGTCGTCTGCGTGCCGAACGCTGGAAAGCGGAAAATCAGGAAGGGATGGC
TGAGGTCGCCCGGTTTATTGAAATGAACGGCTCTTTTGCTGACGAGAACAGGGG
CTGGTGAAATGCAGTTTAAGGTTTACACCTATAAAAGAGAGAGCCGTTATCGTCT
GTTTGTGGATGTACAGAGTGATATTATTGACACGCCCGGGCGACGGATGGTGAT
CCCCCTGGCCAGTGCACGTCTGCTGTCAGATAAAGTCCCCCGTGAACTTTACCC
GGTGGTGCATATCGGGGATGAAAGCTGGCGCATGATGACCACCGATATGGCCA
GTGTGCCGGTCTCCGTTATCGGGGAAGAAGTGGCTGATCTCAGCCACCGCGAAA
ATGACATCAAAAACGCCATTAACCTGATGTTCTGGGGAATATAAATGTCAGGCTC
CCTTATACACAGCCAGTCTGCAGGTCGACCATAGTGACTGGATATGTTGTGTTTT
ACAGTATTATGTAGTCTGTTTTTTATGCAAAATCTAATTTAATATATTGATATTTATA
TCATTTTACGTTTCTCGTTCAGCTTTCTTGTACAAAGTGGTGAGCTCCGCCACCAT
GGATCTCCACCGCGGTGGAGGCCGCATCTTTTACCCATACGATGTTCCTGACTAT
GCGGGCTATCCCTATGACGTCCCGGACTATGCAGGATCCTATCCATATGACGTT
CCAGATTACGCTGCTCATGGCGGACACCGGTCCACGTGACGTAAGCTAGAGGAT
CTTTGTGAAGGAACCTTACTTCTGTGGTGTGACATAATTGGACAAACTACCTACA
GAGATTTAAAGCTCTAAGGTAAATATAAAATTTTTAAGTGTATAATGTGTTAAACTA
CTGATTCTAATTGTTTGTGTATTTTAGATTCCAACCTATGGAACTGATGAATGGGA
GCAGTGGTGGAATGCCTTTAATGAGGAAAACCTGTTTTGCTCAGAAGAAATGCCA
TCTAGTGATGATGAGGCTACTGCTGACTCTCAACATTCTACTCCTCCAAAAAAGA
AGAGAAAGGTAGAAGACCCCAAGGACTTTCCTTCAGAATTGCTAAGTTTTTTGAG
TCATGCTGTGTTTAGTAATAGAACTCTTGCTTGCTTTGCTATTTACACCACAAAGG
AAAAAGCTGCACTGCTATACAAGAAAATTATGGAAAAATATTTGATGTATAGTGCC
TTGACTAGAGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAA
AAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTT
GTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAA
TTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCAT
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CAATGTATCTTATCATGTCTGGATCCACTAGTGTCGACGATGTAGGTCACGGTCT
CGAAGCCGCGGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTA
CTCCACCTCACCCATCTGGTCCATCATGATGAACGGGTCGAGGTGGCGGTAGTT
GATCCCGGCGAACGCGCGGCGCACCGGGAAGCCCTCGCCCTCGAAACCGCTG
GGCGCGGTGGTCACGGTGAGCACGGGACGTGCGACGGCGTCGGCGGGTGCGG
ATACGCGGGGCAGCGTCAGCGGGTTCTCGACGGTCACGGCGGGCATGTCGACA
CTAGTTCTAGCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTTCGAGCTTGGCGT
AATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACAC
AACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGC
TAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGT
CGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGT
ATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGG
CTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAA
TCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAG
GAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGA
CGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACT
ATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCC
GACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGC
GCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCC
AAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCC
GGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCA
GCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGA
GTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATC
TGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCG
GCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTAC
GCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGAC
GCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAA
GGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTA
TATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATC
TCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGA
TAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGC
GAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAA
GGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTA
ATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGT
TGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCA
TTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCA
AAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCG
CAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCA
TCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAAT
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AGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCG
CGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCG
AAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGT
GCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAA
AAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTT
GAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTC
TCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCG
CGCACATTTCCCCGAAAAGTGCCAC
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Appendix E: pUASt-GW-Venus attB (pTWV-attB) anticipated sequence
pUASt-GW-Venus-attB:
UASt promoter: 4861 … 5225
Gateway cassette: 5470 … 7173
attR1: 5470 … 5487
attR2: 7156 … 7173
Venus: 7187 … 7903
CTGAAAATTGTAAGCGTTAATATTTTGTTAAAATTCGCGTTAAATTTTTGTTAAATC
AGCTCATTTTTTAACCAATAGGCCGAAATCGGCAAAATCCCTTATAAATCAAAAGA
ATAGACCGAGATAGGGTTGAGTGTTGTTCCAGTTTGGAACAAGAGTCCACTATTA
AAGAACGTGGACTCCAACGTCAAAGGGCGAAAAACCGTCTATCAGGGCGATGGC
CCACTACGTGAACCATCACCCTAATCAAGTTTTTTGGGGTCGAGGTGCCGTAAAG
CACTAAATCGGAACCCTAAAGGGAGCCCCCGATTTAGAGCTTGACGGGGAAAGC
CGGCGAACGTGGCGAGAAAGGAAGGGAAGAAAGCGAAAGGAGCGGGCGCTAG
GGCGCTGGCAAGTGTAGCGGTCACGCTGCGCGTAACCACCACACCCGCCGCGC
TTAATGCGCCGCTACAGGGCGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGG
GAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGG
ATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACG
TTGTAAAACGACGGCCAGTGAATTGTAATACGACTCACTATAGGGCGAATTGGGT
ACGTACCGGGCCCCTAGTATGTATGTAAGTTAATAAAACCCATTTTTGCGGAAAG
TAGATAAAAAAAACATTTTTTTTTTTTACTGCACTGGATATCATTGAACTTATCTGA
TCAGTTTTAAATTTACTTCGATCCAAGGGTATTTGATGTACCAGGTTCTTTCGATT
ACCTCTCACTCAAAATGACATTCCACTCAAAGTCAGCGCTGTTTGCCTCCTTCTCT
GTCCACAGAAATATCGCCGTCTCTTTCGCCGCTGCGTCCGCTATCTCTTTCGCCA
CCGTTTGTAGCGTTACGTAGCGTCAATGTCCGCCTTCAGTTGCATTTTGTCAGCG
GTTTCGTGACGAAGCTCCAAGCGGTTTACGCCATCAATTAAACACAAAGTGCTGT
GCCAAAACTCCTCTCGCTTCTTATTTTTGTTTGTTTTTTGAGTGATTGGGGTGGTG
ATTGGTTTTGGGTGGGTAAGCAGGGGAAAGTGTGAAAAATCCCGGCAATGGGCC
AAGAGGATCAGGAGCTATTAATTCGCGGAGGCAGCAAACACCCATCTGCCGAGC
ATCTGAACAATGTGAGTAGTACATGTGCATACATCTTAAGTTCACTTGATCTATAG
GAACTGCGATTGCAACATCAAATTGTCTGCGGCGTGAGAACTGCGACCCACAAA
AATCCCAAACCGCAATTGCACAAACAAATAGTGACACGAAACAGATTATTCTGGT
AGCTGTTCTCGCTATATAAGACAATTTTTGAGATCATATCATGATCAAGACATCTA
AAGGCATTCATTTTCGACTATATTCTTTTTTACAAAAAATATAACAACCAGATATTT
TAAGCTGATCCTAGATGCACAAAAAATAAATAAAAGTATAAACCTACTTCGTAGGA
TACTTCGGGGTACTTTTTGTTCGGGGTTAGATGAGCATAACGCTTGTAGTTGATA
TTTGAGATCCCCTATCATTGCAGGGTGACAGCGGAGCGGCTTCGCAGAGCTGCA
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TTAACCAGGGCTTCGGGCAGGCCAAAAACTACGGCACGCTCCGGCCACCCAGT
CCGCCGGAGGACTCCGGTTCAGGGAGCGGCCAACTAGCCGAGAACCTCACCTA
TGCCTGGCACAATATGGACATCTTTGGGGCGGTCAATCAGCCGGGCTCCGGATG
GCGGCAGCTGGTCAACCGGACACGCGGACTATTCTGCAACGAGCGACACATAC
CGGCGCCCAGGAAACATTTGCTCAAGAACGGTGAGTTTCTATTCGCAGTCGGCT
GATCTGTGTGAAATCTTAATAAAGGGTCCAATTACCAATTTGAAACTCAGTTTGCG
GCGTGGCCTATCCGGGCGAACTTTTGGCCGTGATGGGCAGTTCCGGTGCCGGA
AAGACGACCCTGCTGAATGCCCTTGCCTTTCGATCGCCGCAGGGCATCCAAGTA
TCGCCATCCGGGATGCGACTGCTCAATGGCCAACCTGTGGACGCCAAGGAGAT
GCAGGCCAGGTGCGCCTATGTCCAGCAGGATGACCTCTTTATCGGCTCCCTAAC
GGCCAGGGAACACCTGATTTTCCAGGCCATGGTGCGGATGCCACGACATCTGAC
CTATCGGCAGCGAGTGGCCCGCGTGGATCAGGTGATCCAGGAGCTTTCGCTCA
GCAAATGTCAGCACACGATCATCGGTGTGCCCGGCAGGGTGAAAGGTCTGTCCG
GCGGAGAAAGGAAGCGTCTGGCATTCGCCTCCGAGGCACTAACCGATCCGCCG
CTTCTGATCTGCGATGAGCCCACCTCCGGACTGGACTCATTTACCGCCCACAGC
GTCGTCCAGGTGCTGAAGAAGCTGTCGCAGAAGGGCAAGACCGTCATCCTGACC
ATTCATCAGCCGTCTTCCGAGCTGTTTGAGCTCTTTGACAAGATCCTTCTGATGG
CCGAGGGCAGGGTAGCTTTCTTGGGCACTCCCAGCGAAGCCGTCGACTTCTTTT
CCTAGTGAGTTCGATGTGTTTATTAAGGGTATCTAGCATTACATTACATCTCAACT
CCTATCCAGCGTGGGTGCCCAGTGTCCTACCAACTACAATCCGGCGGACTTTTA
CGTACAGGTGTTGGCCGTTGTGCCCGGACGGGAGATCGAGTCCCGTGATCGGA
TCGCCAAGATATGCGACAATTTTGCTATTAGCAAAGTAGCCCGGGATATGGAGCA
GTTGTTGGCCACCAAAAATTTGGAGAAGCCACTGGAGCAGCCGGAGAATGGGTA
CACCTACAAGGCCACCTGGTTCATGCAGTTCCGGGCGGTCCTGTGGCGATCCTG
GCTGTCGGTGCTCAAGGAACCACTCCTCGTAAAAGTGCGACTTATTCAGACAAC
GGTGAGTGGTTCCAGTGGAAACAAATGATATAACGCTTACAATTCTTGGAAACAA
ATTCGCTAGATTTTAGTTAGAATTGCCTGATTCCACACCCTTCTTAGTTTTTTTCAA
TGAGATGTATAGTTTATAGTTTTGCAGAAAATAAATAAATTTCATTTAACTCGCGAA
CATGTTGAAGATATGAATATTAATGAGATGCGAGTAACATTTTAATTTGCAGATGG
TTGCCATCTTGATTGGCCTCATCTTTTTGGGCCAACAACTCACGCAAGTGGGCGT
GATGAATATCAACGGAGCCATCTTCCTCTTCCTGACCAACATGACCTTTCAAAAC
GTCTTTGCCACGATAAATGTAAGTCTTGTTTAGAATACATTTGCATATTAATAATTT
ACTAACTTTCTAATGAATCGATTCGATTTAGGTGTTCACCTCAGAGCTGCCAGTTT
TTATGAGGGAGGCCCGAAGTCGACTTTATCGCTGTGACACATACTTTCTGGGCAA
AACGATTGCCGAATTACCGCTTTTTCTCACAGTGCCACTGGTCTTCACGGCGATT
GCCTATCCGATGATCGGACTGCGGGCCGGAGTGCTGCACTTCTTCAACTGCCTG
GCGCTGGTCACTCTGGTGGCCAATGTGTCAACGTCCTTCGGATATCTAATATCCT
GCGCCAGCTCCTCGACCTCGATGGCGCTGTCTGTGGGTCCGCCGGTTATCATAC
CATTCCTGCTCTTTGGCGGCTTCTTCTTGAACTCGGGCTCGGTGCCAGTATACCT
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CAAATGGTTGTCGTACCTCTCATGGTTCCGTTACGCCAACGAGGGTCTGCTGATT
AACCAATGGGCGGACGTGGAGCCGGGCGAAATTAGCTGCACATCGTCGAACAC
CACGTGCCCCAGTTCGGGCAAGGTCATCCTGGAGACGCTTAACTTCTCCGCCGC
CGATCTGCCGCTGGACTACGTGGGTCTGGCCATTCTCATCGTGAGCTTCCGGGT
GCTCGCATATCTGGCTCTAAGACTTCGGGCCCGACGCAAGGAGTAGCCGACATA
TATCCGAAATAACTGCTTGTTTTTTTTTTTTACCATTATTACCATCGTGTTTACTGTT
TATTGCCCCCTCAAAAAGCTAATGTAATTATATTTGTGCCAATAAAAACAAGATAT
GACCTATAGAATACAAGTATTTCCCCTTCGAACATCCCCACAAGTAGACTTTGGAT
TTGTCTTCTAACCAAAAGACTTACACACCTGCATACCTTACATCAAAAACTCGTTT
ATCGCTACATAAAACACCGGGATATATTTTTTATATACATACTTTTCAAATCGCGC
GCCCTCTTCATAATTCACCTCCACCACACCACGTTTCGTAGTTGCTCTTTCGCTGT
CTCCCACCCGCTCTCCGCAACACATTCACCTTTTGTTCGACGACCTTGGAGCGAC
TGTCGTTAGTTCCGCGCGATTCGGTTCGCTCAAATGGTTCCGAGTGGTTCATTTC
GTCTCAATAGAAATTAGTAATAAATATTTGTATGTACAATTTATTTGCTCCAATATA
TTTGTATATATTTCCCTCACAGCTATATTTATTCTAATTTAATATTATGACTTTTTAA
GGTAATTTTTTGTGACCTGTTCGGAGTGATTAGCGTTACAATTTGAACTGAAAGTG
ACATCCAGTGTTTGTTCCTTGTGTAGATGCATCTCAAAAAAATGGTGGGCATAATA
GTGTTGTTTATATATATCAAAAATAACAACTATAATAATAAGAATACATTTAATTTAG
AAAATGCTTGGATTTCACTGGAACTAGGCTAGCATAACTTCGTATAATGTATGCTA
TACGAAGTTATGCTAGCGGATCCAAGCTTGCATGCCTGCAGGTCGGAGTACTGT
CCTCCGAGCGGAGTACTGTCCTCCGAGCGGAGTACTGTCCTCCGAGCGGAGTA
CTGTCCTCCGAGCGGAGTACTGTCCTCCGAGCGGAGACTCTAGCGAGCGCCGG
AGTATAAATAGAGGCGCTTCGTCTACGGAGCGACAATTCAATTCAAACAAGCAAA
GTGAACACGTCGCTAAGCGAAAGCTAAGCAAATAAACAAGCGCAGCTGAACAAG
CTAAACAATCTGCAGTAAAGTGCAAGTTAAAGTGAATCAATTAAAAGTAACCAGCA
ACCAAGTAAATCAACTGCAACTACTGAAATCTGCCAAGAAGTAATTATTGAATACA
AGAAGAGAACTCTGAATAGGGAATTGGGAATTGCAAAATGCACCATCACCACCAT
CACGGATTCGAGCTATGCGGCCGCTCTGAGCAAAAGCTCATTTCTGAAGAGGAC
TTGAATGGAGAACAGAAATTGATCAGTGAGGAAGACCTCAACGGTGAGCAGAAG
TTAATATCCGAGGAGGATCTTAATAGTAGCGGCCGCACTAGTCTCGAAGGGGGG
CCCCATATGTTGACTGTATCGCCGGAATTGGGAATTATCGACAAGTTTGTACAAA
AAAGCTGAACGAGAAACGTAAAATGATATAAATATCAATATATTAAATTAGATTTTG
CATAAAAAACAGACTACATAATACTGTAAAACACAACATATCCAGTCACTATGGCG
GCCGCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGTATAATGTGT
GGATTTTGAGTTAGGATCCGTCGAGATTTTCAGGAGCTAAGGAAGCTAAAATGGA
GAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAA
CATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCT
GGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGG
CCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGC
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AATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTT
TTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATT
TCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCT
GGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCT
GGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGC
CCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCC
GCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAAT
GCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGCGGGGCGTAATCTAGA
GGATCCGGCTTACTAAAAGCCAGATAACAGTATGCGTATTTGCGCGCTGATTTTT
GCGGTATAAGAATATATACTGATATGTATACCCGAAGTATGTCAAAAAGAGGTAT
GCTATGAAGCAGCGTATTACAGTGACAGTTGACACCGACAGCTATCAGTTGCTCA
AGGCATATATGATGTCAATATCTCCGGTCTGGTAAGCACAACCATGCAGAATGAA
GCCCGTCGTCTGCGTGCCGAACGCTGGAAAGCGGAAAATCAGGAAGGGATGGC
TGAGGTCGCCCGGTTTATTGAAATGAACGGCTCTTTTGCTGACGAGAACAGGGG
CTGGTGAAATGCAGTTTAAGGTTTACACCTATAAAAGAGAGAGCCGTTATCGTCT
GTTTGTGGATGTACAGAGTGATATTATTGACACGCCCGGGCGACGGATGGTGAT
CCCCCTGGCCAGTGCACGTCTGCTGTCAGATAAAGTCCCCCGTGAACTTTACCC
GGTGGTGCATATCGGGGATGAAAGCTGGCGCATGATGACCACCGATATGGCCA
GTGTGCCGGTCTCCGTTATCGGGGAAGAAGTGGCTGATCTCAGCCACCGCGAAA
ATGACATCAAAAACGCCATTAACCTGATGTTCTGGGGAATATAAATGTCAGGCTC
CCTTATACACAGCCAGTCTGCAGGTCGACCATAGTGACTGGATATGTTGTGTTTT
ACAGTATTATGTAGTCTGTTTTTTATGCAAAATCTAATTTAATATATTGATATTTATA
TCATTTTACGTTTCTCGTTCAGCTTTCTTGTACAAAGTGGTGAGCTCCGCCACCAT
GGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGC
TGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGC
GATGCCACCTACGGCAAGCTGACCCTGAAGCTGATCTGCACCACCGGCAAGCTG
CCCGTGCCCTGGCCCACCCTCGTGACCACCCTGGGCTACGGCCTGCAGTGCTT
CGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCC
CGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAA
GACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGC
TGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAG
TACAACTACAACAGCCACAACGTCTATATCACCGCCGACAAGCAGAAGAACGGC
ATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCGGCGTGCAGCTC
GCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCC
CGACAACCACTACCTGAGCTACCAGTCCGCCCTGAGCAAAGACCCCAACGAGAA
GCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCG
GCATGGACGAGCTGTACAAGCACCGGTCCACGTGACGTAAGCTAGAGGATCTTT
GTGAAGGAACCTTACTTCTGTGGTGTGACATAATTGGACAAACTACCTACAGAGA
TTTAAAGCTCTAAGGTAAATATAAAATTTTTAAGTGTATAATGTGTTAAACTACTGA
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TTCTAATTGTTTGTGTATTTTAGATTCCAACCTATGGAACTGATGAATGGGAGCAG
TGGTGGAATGCCTTTAATGAGGAAAACCTGTTTTGCTCAGAAGAAATGCCATCTA
GTGATGATGAGGCTACTGCTGACTCTCAACATTCTACTCCTCCAAAAAAGAAGAG
AAAGGTAGAAGACCCCAAGGACTTTCCTTCAGAATTGCTAAGTTTTTTGAGTCAT
GCTGTGTTTAGTAATAGAACTCTTGCTTGCTTTGCTATTTACACCACAAAGGAAAA
AGCTGCACTGCTATACAAGAAAATTATGGAAAAATATTTGATGTATAGTGCCTTGA
CTAGAGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAA
CCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTA
ACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCA
CAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAAT
GTATCTTATCATGTCTGGATCCACTAGTGTCGACGATGTAGGTCACGGTCTCGAA
GCCGCGGTGCGGGTGCCAGGGCGTGCCCTTGGGCTCCCCGGGCGCGTACTCC
ACCTCACCCATCTGGTCCATCATGATGAACGGGTCGAGGTGGCGGTAGTTGATC
CCGGCGAACGCGCGGCGCACCGGGAAGCCCTCGCCCTCGAAACCGCTGGGCG
CGGTGGTCACGGTGAGCACGGGACGTGCGACGGCGTCGGCGGGTGCGGATAC
GCGGGGCAGCGTCAGCGGGTTCTCGACGGTCACGGCGGGCATGTCGACACTAG
TTCTAGCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTTCGAGCTTGGCGTAATCA
TGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACAT
ACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACT
CACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTG
CCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTG
GGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGC
GGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAG
GGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAAC
CGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAG
CATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAA
AGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACC
CTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTT
TCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGC
TGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTA
ACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAG
CCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCT
TGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCG
CTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAA
ACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGC
AGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTC
AGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGAT
CTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATA
TGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCA

97
GCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAA
CTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAG
ACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGG
CCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTG
TTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTT
GCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCA
GCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAA
AGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGT
GTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCG
TAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGT
ATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCA
CATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAAC
TCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACC
CAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACA
GGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATA
CTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATG
AGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCA
CATTTCCCCGAAAAGTGCCAC
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Appendix F. Adult flies survival curves in the CycY tissue wide knockdown
screen (Continued)
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Appendix G. Wilcoxon Rank Sum p-values for the adult flies survival test in
the CycY tissue wide knockdown screen.
Males
Exp. 1
Exp. 2
Exp. 3
Gal4
No
Gal4
0.327
NA
0.021
line
pnr
NA
0.035
5.516Een
ND
ND
ND
05
Sca
NA
NA
0.021
C253
0.015
NA
0.182
MHC
0.564
0.300
0.317
Eip71CD 0.151
0.003
0.049
Ser
ND
ND
ND
cg
NA
NA
0.048
vg
0.334
0.005
2.199 E4G
0.074
NA
0.137
04
D42
0.002
NA
NA
48Y
ND
2.182E-05 5.627EOK376
NA
NA
NA
06
Sgs3
NA
0.064
NA
Dpp
0.062
0.009
112A
0.010
9.139E0.0004.7
Mef2
NA
0.057
5.577E05
40E-04
Feb36
0.317
NA
0.037
07
Aug21
0.031
0.304
NA
Hml
0.503
NA
0.251
c601
NA
NA
NA
c578
NA
NA
NA
r4
0.106
NA
0.160
Wg
NA
0.078
NA
Repo
0.078
0.274
0.173
GMR
0.032
NA
NA
ELAV
0.003
0.233
0.001
NA= Not applicable. ND= Not done

Exp. 1
0.003
0.001
0.056
NA
0.089
NA
NA
0.030
0.014
0.051
1.590E-04
6.912E-05
ND
NA
NA
0.002
1.743E-06
1.015E-10
0.015
0.002
1.584E-08
NA
0.017
NA
NA
NA
NA
2.607E-06

Females
Exp. 2
0.263
NA
0.004
NA
NA
NA
7.792E-05
NA
NA
NA
NA
1.606E-04
1.507E-06
NA
0.450
NA
NA
NA
0.094
3.295E-05
0.055
4.782E-08
0.019
NA
NA
0.037
NA
0.013

Exp. 3
NA
1.783 E3.655E04
2.682E06
NA
06
NA
0.001
1.293E1.312E06
2.187E04
7.350E09
7.569E05
1.436E06
NA
06
NA
0.001
NA
NA
NA
1.488E3.368E04
1.120E04
NA
05
NA
NA
0.095
NA
9.385E07
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Appendix H. Fly strains used in the study described in chapters 3 & 4
Finely
lab #
274

Stock
center &
numbers
Bl 3041

Alias

Genotypes

Reference

ap-Gal4

y[1] w[1118]; P{w[+mW.hs]=GawB}

(Brand and
Perrimon,
1993)
(Brand and
Perrimon,
1993; Sigrist
and Lehner,
(Fleming,
1997)
2003)

ap[md544]/CyO,P{w[+mC]=ActGFP}JMR1
284

Bl 6356

en-Gal4

y[1] w[*]; P{w[+mW.hs]=en2.4-GAL4}e16E
P{w[+mC]=UAS-FLP1.D}JD1

426

Bl 6791

ser-Gal4

w[*]; P{w[+mC]=Ser-GAL4.GF}1 P{SerGAL4.GF}2

923

Bl 31473

UAS-arr
dsRNA

y[1] v[1]; P{y[+t7.7]
v[+t1.8]=TRiP.JF01261}attP2

(Ni et al.,
2008)

923

Bl 35287

UAS-Cdk5
shRNA

y[1] sc[*] v[1]; P{y[+t7.7]

(Ni et al.,
2011)

v[+t1.8]=TRiP.GL00189}attP2

980

Bl 9116

UASLIMK1

y[1] w[*]; P{w[+mC]=UASLIMK1.T:Ivir\HA1 }

(Ng and
Luo, 2004)

447

Andreas
bergmann’s lab

UAS-p35

M6
UAS-p35;
TM3, Ser/Sb

N/A
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Cyclin Y is a highly conserved member of the Cyclin superfamily of proteins.
In Drosophila the Cyclin Y gene (CycY) is required for progression through several
stages of development but the specific pathways that Cyclin Y belongs to and that
account for its requirement are not known. Studies in human and Drosophila cell
lines have shown that membrane-localized Cyclin Y is required for phosphorylation
of the wingless/Wnt co-receptor, arrow/LRP6, and for full activation of the canonical
wingless/Wnt pathway. CycY null Drosophila, however, do not phenocopy loss-offunction mutations in canonical wingless pathway genes, suggesting that Cyclin Y
may have additional roles outside the wingless pathway in vivo. To identify roles for
Cyclin Y in Drosophila I used RNAi to knock down CycY expression in 31 distinct
tissue patterns. The screen revealed that expression of the CycY shRNA in specific
tissue patterns causes larval lethality and other developmental defects. Knockdown
of CycY but not arrow in imaginal discs resulted in bent legs and blistered wings,
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suggesting defects in the cell adhesion pathway. A transgene expressing a Cyclin Y
variant that is not membrane localized suppresses some of the CycY knockdown
phenotypes, further suggesting that they are not due to defective Arrow
phosphorylation. Genetic and phenotypic evidence suggest that Cyclin Y interacts
with the Rho pathway to regulate cell adhesion.
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